{"ctNumber":"2022-503112-17-00","ctStatus":"Authorised","startDateEU":"2024-10-16","decisionDate":"2024-06-03T15:51:34.327","publishDate":"2026-07-18T03:36:46.133207468","ctPublicStatusCode":3,"authorizedApplication":{"authorizedPartI":{"id":137148,"rowSubjectCount":7,"rowCountriesInfo":[{"eutctId":100000000556,"name":"United Kingdom","isoNumber":826,"isoAlpha2Code":"GB","isoAlpha3Code":"GBR","current":true},{"eutctId":100000000549,"name":"Turkey","isoNumber":792,"isoAlpha2Code":"TR","isoAlpha3Code":"TUR","current":true},{"eutctId":100000000557,"name":"United States","isoNumber":840,"isoAlpha2Code":"US","isoAlpha3Code":"USA","current":true}],"products":[{"id":570846,"part1MpRoleTypeCode":"3","productDictionaryInfo":{"euMpNumber":"SUB10020MIG","marketingAuthNumber":"-","prodAuthStatus":2,"prodName":"PREDNISONE","pharmForm":"TABLET","activeSubstanceName":"PREDNISONE","euSubstNumber":"SUB10020MIG","productSubstances":[{"substancePk":"172490","actSubstOrigin":"Chemical","actSubstName":"PREDNISONE","substanceEvCode":"SUB10020MIG"}],"atcCode":"-","atcName":"-","atcTermLevel":"-","activeSubstanceOtherDescriptiveName":"prednisone or equivalent"},"isPaediatricFormulation":false,"mpRoleInTrial":"4","orphanDrugEdit":false,"doseUom":"mg milligram(s)","maxDailyDoseAmount":"60","doseUomTotal":"mg milligram(s)","maxTotalDoseAmount":"60","productChangedRelationMA":false,"maxTreatmentPeriod":12,"timeUnitCode":"2","otherMedicinalProduct":"Anti-inflamatory properties similar to other corticoids","scientificProductEvCode":"SUB10020MIG","devices":[],"characteristics":["11"],"routes":["ORAL"],"allSubstancesChemicals":false,"productName":"PREDNISONE","jsonActiveSubstanceNames":"prednisone"},{"id":570845,"part1MpRoleTypeCode":"3","productDictionaryInfo":{"euMpNumber":"SUB10020MIG","marketingAuthNumber":"-","prodAuthStatus":2,"prodName":"PREDNISONE","pharmForm":"TABLET","activeSubstanceName":"PREDNISONE","euSubstNumber":"SUB10020MIG","productSubstances":[{"substancePk":"173026","actSubstOrigin":"Chemical","actSubstName":"PREDNISONE","substanceEvCode":"SUB10020MIG"}],"atcCode":"-","atcName":"-","atcTermLevel":"-","activeSubstanceOtherDescriptiveName":"prednisone or equivalent"},"isPaediatricFormulation":false,"mpRoleInTrial":"4","orphanDrugEdit":false,"doseUom":"mg milligram(s)","maxDailyDoseAmount":"60","doseUomTotal":"mg milligram(s)","maxTotalDoseAmount":"60","productChangedRelationMA":false,"maxTreatmentPeriod":12,"timeUnitCode":"2","otherMedicinalProduct":"Anti-inflamatory properties similar to other corticoids","scientificProductEvCode":"SUB10020MIG","devices":[],"characteristics":["11"],"routes":["ORAL"],"allSubstancesChemicals":false,"productName":"PREDNISONE","jsonActiveSubstanceNames":"prednisone"},{"id":570847,"part1MpRoleTypeCode":"3","productDictionaryInfo":{"euMpNumber":"SUB10020MIG","marketingAuthNumber":"-","prodAuthStatus":2,"prodName":"PREDNISONE","pharmForm":"TABLET","activeSubstanceName":"PREDNISONE","euSubstNumber":"SUB10020MIG","productSubstances":[{"substancePk":"71836","actSubstOrigin":"Chemical","actSubstName":"PREDNISONE","substanceEvCode":"SUB10020MIG"}],"atcCode":"-","atcName":"-","atcTermLevel":"-","activeSubstanceOtherDescriptiveName":"prednisone or equivalent"},"isPaediatricFormulation":false,"mpRoleInTrial":"4","orphanDrugEdit":false,"doseUom":"mg milligram(s)","maxDailyDoseAmount":"60","doseUomTotal":"mg milligram(s)","maxTotalDoseAmount":"60","productChangedRelationMA":false,"maxTreatmentPeriod":12,"timeUnitCode":"2","otherMedicinalProduct":"Anti-inflamatory properties similar to other corticoids","scientificProductEvCode":"SUB10020MIG","devices":[],"characteristics":["11"],"routes":["ORAL"],"allSubstancesChemicals":false,"productName":"PREDNISONE","jsonActiveSubstanceNames":"prednisone"},{"id":570848,"part1MpRoleTypeCode":"1","productDictionaryInfo":{"productPk":"10893265","productPharmForm":"VIAL FOR INTRAVENOUS USE","euMpNumber":"PRD10893265","prodAuthStatus":1,"prodName":"SRP-9003","pharmForm":"VIAL FOR INTRAVENOUS USE","sponsorProductCode":"SRP-9003","activeSubstanceName":"BIDRIDISTROGENE XEBOPARVOVEC","euSubstNumber":"SUB207366","nameOrg":"SAREPTA THERAPEUTICS INC","productSubstances":[{"productPk":"10893265","substancePk":"339860","nameOrg":"SAREPTA THERAPEUTICS INC","substanceOrigin":"Structurally Diverse Substance - Other","actSubstOrigin":"Structurally Diverse Substance - Other","actSubstName":"BIDRIDISTROGENE XEBOPARVOVEC","substanceEvCode":"SUB207366"}],"activeSubstanceOtherDescriptiveName":""},"isPaediatricFormulation":false,"mpRoleInTrial":"1","orphanDrugEdit":true,"orphanDrugDesigNumber":"EU/3/20/2365","doseUom":"DF dosage form","maxDailyDoseAmount":"74100000000000","doseUomTotal":"DF dosage form","maxTotalDoseAmount":"74100000000000","maxTreatmentPeriod":60,"timeUnitCode":"3","otherMedicinalProduct":"Containing GMO(s)","evCode":"PRD10893265","sponsorProductCodeEdit":"SRP-9003","therapies":[{"id":7372,"advancedTherapyType":"3","geneOfInterest":"β-sarcoglycan","description":"recombinant AAV","isInVivo":true,"geneTransferProductType":"3"}],"devices":[],"characteristics":["11","7"],"routes":["INTRAVENIOUS INFUSION"],"allSubstancesChemicals":false,"productName":"SRP-9003","jsonActiveSubstanceNames":"bidridistrogene xeboparvovec","pharmaceuticalFormDisplay":"VIAL FOR INTRAVENOUS USE"}],"trialDetails":{"clinicalTrialIdentifiers":{"fullTitle":"A Phase 3 Multinational, Open-label, Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9003 in Subjects with Limb Girdle Muscular Dystrophy 2E/R4 (EMERGENE)","fullTitleTranslations":[],"publicTitle":"Open-label, Phase 3 Gene Delivery Study with SRP-9003 in LGMD 2E/R4 Subjects","publicTitleTranslations":[],"shortTitle":"SRP-9003-301","secondaryIdentifyingNumbers":{"additionalRegistries":[]}},"trialInformation":{"trialCategory":{"isLowIntervention":false,"trialPhase":"5","trialCategory":"2","justificationForTrialCategory":"According to the \"Appendix on transparency rules to the functional specifications of the EU clinical trials portal and database\" chapter 4.3.3, Category 2 trials are safety and efficacy trials in patients, and include phase III trials carried out to investigate the safety and efficacy of the investigational medicinal product. The current study meets this requirement, as SRP-9003-301 is a Phase III study conducted to Investigate the Efficacy and Safety of SRP-9003 in Subjects with Limb Girdle Muscular Dystrophy 2E/R4","trialCategoryId":126605},"medicalCondition":{"partIMedicalConditions":[{"id":143480,"medicalCondition":"Limb-girdle muscular dystrophy, type 2E/R4 (LGMD2E/R4) or β-sarcoglycanopathy","medicalConditionTranslations":[],"isConditionRareDisease":true}],"meddraConditionTerms":[{"termId":100000004850,"version":"20.0","level":"SOC","termName":"Congenital familial and genetic disorders","classificationCode":"10010331","organClass":21,"active":false}]},"trialObjective":{"trialScopes":[{"code":"5","trialScopeId":416637},{"code":"4","trialScopeId":416638}],"mainObjective":"To evaluate the effect of SRP-9003 on β-sarcoglycan (β-SG) expression at Day 60 post-dose as measured by immunofluorescence (IF) percent β-SG positive fibers (PβSGPF)  for subjects in Cohort 1 (ambulatory subjects)","mainObjectiveTranslations":[],"secondaryObjectives":[{"id":488986,"number":1,"secondaryObjective":"To evaluate the effect of SRP-9003 on β-SG expression at Day 60 post-dose as measured by IF percent fluorescent intensity (PFI) and Western assay of biopsied muscle tissue for subjects in  Cohorts 1 (ambulatory subjects) and 2 (non ambulatory subjects)","secondaryObjectiveTranslations":[]},{"id":488987,"number":2,"secondaryObjective":"To evaluate the effect of SRP-9003 on β-sarcoglycan (β-SG) expression at Day 60 post-dose as measured by immunofluorescence (IF) percent β-SG positive fibers (PβSGPF) for subjects in Cohort 2 (non-ambulatory  subjects)","secondaryObjectiveTranslations":[]},{"id":488988,"number":3,"secondaryObjective":"To evaluate the effect of SRP-9003 on physical function through Month 60 in all cohorts, as assessed by: − North Star Assessment for Limb-girdle Muscular Dystrophies  (NSAD) score − Performance of Upper Limb (PUL) 2.0 score","secondaryObjectiveTranslations":[]},{"id":488989,"number":4,"secondaryObjective":"To evaluate the effect of SRP-9003 timed function tests for subjects in Cohort 1 (ambulatory subject) through Month 60","secondaryObjectiveTranslations":[]},{"id":488990,"number":5,"secondaryObjective":"To evaluate the safety of SRP-9003","secondaryObjectiveTranslations":[]},{"id":488991,"number":6,"secondaryObjective":"To evaluate the effect of SRP-9003 on creatine kinase (CK) level","secondaryObjectiveTranslations":[]},{"id":488992,"number":7,"secondaryObjective":"To evaluate the effect of SRP-9003 on disease milestones (eg, loss of ambulation [LOA])","secondaryObjectiveTranslations":[]}]},"eligibilityCriteria":{"principalInclusionCriteria":[{"id":932146,"number":1,"principalInclusionCriteria":"Cohort 1, only ambulatory subjects - ≥ 4 years of age - Able to walk without assistive aid - 10MWR < 30 seconds - NSAD total score ≥ 25","principalInclusionCriteriaTranslations":[]},{"id":932147,"number":2,"principalInclusionCriteria":"Cohort 2, only non-ambulatory subjects − ≥ 4 years of age − 10MWR ≥ 30 seconds or unable to perform − PUL 2.0 entry scale score ≥ 3","principalInclusionCriteriaTranslations":[]},{"id":932148,"number":3,"principalInclusionCriteria":"Has AAVrh74 antibody titers < 1:400 (ie, not elevated) as determined by  AAVrh74 Antibody ELISA.","principalInclusionCriteriaTranslations":[]},{"id":932149,"number":4,"principalInclusionCriteria":"Is willing to provide informed consent. Alternatively, is willing to provide assent (if applicable) and has (a) parent(s) or legal guardian(s) who is (are) willing to provide informed consent for the subject to participate in the study.","principalInclusionCriteriaTranslations":[]},{"id":932150,"number":5,"principalInclusionCriteria":"Willing and able to comply with the study protocol required assessments","principalInclusionCriteriaTranslations":[]},{"id":932151,"number":6,"principalInclusionCriteria":"Possesses 1 homozygous or 2 heterozygous pathogenic and/or likely pathogenic β-SG DNA gene mutations as documented prior to Screening. Results to be confirmed by Sponsor at a CLIA/CAP/ISO15189 certified laboratory prior to dosing.","principalInclusionCriteriaTranslations":[]},{"id":932152,"number":7,"principalInclusionCriteria":"Able to cooperate with muscle testing","principalInclusionCriteriaTranslations":[]},{"id":932153,"number":8,"principalInclusionCriteria":"Male or female who are of childbearing potential must agree to use, through Month 24, a highly-effective method of contraception (Appendix 1)., Section 11.4.1.1). A woman is considered of childbearing potential (i.e., fertile) following menarche and until becoming post-menopausal unless permanently sterile. Permanent sterilization methods include hysterectomy, bilateral salpingectomy and bilateral oophorectomy.","principalInclusionCriteriaTranslations":[]},{"id":932154,"number":9,"principalInclusionCriteria":"Stable dose equivalent of oral glucocorticoids for at least 12 weeks before Screening/Baseline and the dose is expected to remain constant (except for modifications to accommodate changes in weight) throughout the first year of the study","principalInclusionCriteriaTranslations":[]}],"principalExclusionCriteria":[{"id":1592983,"number":1,"principalExclusionCriteria":"Has a symptomatic infection (eg, upper respiratory tract infection, pneumonia, pyelonephritis, meningitis) within 4 weeks before study treatment infusion (in such case, enrollment may be postponed). If symptomatic infection occurs between Day -7 (±3d) baseline testing and infusion baseline Day 1, the baseline Day -7 (±3d) testing will need to be repeated.","principalExclusionCriteriaTranslations":[]},{"id":1592984,"number":10,"principalExclusionCriteria":"Any contraindication to the use of glucocorticoids.","principalExclusionCriteriaTranslations":[]},{"id":1592985,"number":11,"principalExclusionCriteria":"Has hypersensitivity to any component of the study drug","principalExclusionCriteriaTranslations":[]},{"id":1592986,"number":12,"principalExclusionCriteria":"Major surgery within 3 months prior to Day 1 or planned surgery or procedure that would interfere with the conduct of the study for any time during this study","principalExclusionCriteriaTranslations":[]},{"id":1592987,"number":13,"principalExclusionCriteria":"Treatment with any of the following therapies according to the time frames specified • Any time: − Gene therapy − Cell based therapy (eg, stem cell transplantation) − Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), or any other form of gene editing • Within 3 months of Day 1: − Use of human growth factor • Within 6 months of the Screening/Baseline visit: Any investigational medication (other than glucocorticoids)","principalExclusionCriteriaTranslations":[]},{"id":1592988,"number":2,"principalExclusionCriteria":"Has received a live virus vaccine within 4 weeks or an inactive vaccine (including a coronavirus disease vaccine) within 2 weeks of the Day 1 visit or expects to receive a vaccine during the first 3 months after Day 1.","principalExclusionCriteriaTranslations":[]},{"id":1592989,"number":3,"principalExclusionCriteria":"Has LVEF < 40% on the Screening/Baseline ECHO or clinical signs and/or symptoms of cardiomyopathy","principalExclusionCriteriaTranslations":[]},{"id":1592990,"number":4,"principalExclusionCriteria":"Has FVC ≤ 40% of predicted value at Screening/Baseline and/or requirement for nocturnal ventilation.","principalExclusionCriteriaTranslations":[]},{"id":1592991,"number":5,"principalExclusionCriteria":"Serological evidence of current, chronic, or active human immunodeficiency virus infection, or hepatitis B or C infection or active viral or bacterial infection based on clinical observations.","principalExclusionCriteriaTranslations":[]},{"id":1592992,"number":6,"principalExclusionCriteria":"Diagnosis of (or ongoing treatment for) an autoimmune disease and on active immunosuppressant treatment.","principalExclusionCriteriaTranslations":[]},{"id":1592993,"number":7,"principalExclusionCriteria":"Has abnormal laboratory values considered clinically significant by the Investigator upon medical review including but not limited to: − Gamma-glutamyl transferase upper limit normal (ULN) − Total bilirubin ULN. Note that elevations on total bilirubin due to Gilbert’s syndrome are not exclusionary. − White blood cell count − Platelets","principalExclusionCriteriaTranslations":[]},{"id":1592994,"number":8,"principalExclusionCriteria":"Presence of any other clinically significant illness or medical condition, including cardiac, hepatic, renal, hematologic, immunologic, neuromuscular (other than LGMD2E/R4), or behavioral disease, or infection or malignancy or concomitant illness or requirement for chronic drug treatment that in the opinion of the Investigator creates unnecessary risks for gene transfer or a medical condition or extenuating circumstance that, in the opinion of the Investigator, might compromise the subject’s ability to comply with the protocol required testing or procedures or compromise the subject’s wellbeing, safety, or clinical interpretability.","principalExclusionCriteriaTranslations":[]},{"id":1592995,"number":9,"principalExclusionCriteria":"Orthopedic comorbidity, such as scoliosis or joint contractures in the upper or lower extremity that would significantly inhibit accurate motor function testing, in the opinion of the Investigator.","principalExclusionCriteriaTranslations":[]}]},"endPoint":{"primaryEndPoints":[{"id":1089041,"number":1,"endPoint":"Change from Baseline in β-SG expression at Day 60 post-dose as measured by IF PβSGPF for subjects in Cohort 1 (ambulatory subjects)","isPrimary":true,"endPointTranslations":[]}],"secondaryEndPoints":[{"id":1089042,"number":1,"endPoint":"Change from Baseline in β-SG expression at Day 60 post-dose as measured by IF PβSGPF for subjects in Cohort 1 (ambulatory subjects)","isPrimary":false,"endPointTranslations":[]},{"id":1089043,"number":2,"endPoint":"Change from Baseline in β-SG expression at Day 60 post-dose for subjects in Cohorts 1 (ambulatory subjects) and 2 (non-ambulatory subjects)  as measured by IF PFI","isPrimary":false,"endPointTranslations":[]},{"id":1089044,"number":3,"endPoint":"Change from Baseline in β-SG expression at Day 60 post-dose as measured by Western","isPrimary":false,"endPointTranslations":[]},{"id":1089045,"number":4,"endPoint":"Change from Baseline in β-SG expression at Day 60  post-dose as measured by IF PβSGPF for subjects in  Cohort 2 (non-ambulatory subjects)","isPrimary":false,"endPointTranslations":[]},{"id":1089046,"number":5,"endPoint":"Change from Baseline through Month 60 in the following physical function for subjects in Cohorts 1(ambulatory subject) and 2 (non-ambulatory subject) − NSAD total score − PUL 2.0 total score","isPrimary":false,"endPointTranslations":[]},{"id":1089047,"number":6,"endPoint":"Change from Baseline through Month 60 in the following timed function tests for subjects in Cohort 1 (ambulatory subject): − Time to rise from the floor − Time to complete the 10MWR − Time to ascend 4 steps − Time to complete the 100MWR − Timed up and go","isPrimary":false,"endPointTranslations":[]},{"id":1089048,"number":7,"endPoint":"Incidence of TEAEs","isPrimary":false,"endPointTranslations":[]},{"id":1089049,"number":8,"endPoint":"Incidence of adverse events of special interest","isPrimary":false,"endPointTranslations":[]},{"id":1089050,"number":9,"endPoint":"Incidence of treatment-emergent SAEs","isPrimary":false,"endPointTranslations":[]},{"id":1089051,"number":10,"endPoint":"Incidence of clinically significant laboratory abnormalities","isPrimary":false,"endPointTranslations":[]},{"id":1089052,"number":11,"endPoint":"Clinically significant changes in ECGs, ECHOs","isPrimary":false,"endPointTranslations":[]},{"id":1089053,"number":12,"endPoint":"Change from Baseline through Month 60 in CK level","isPrimary":false,"endPointTranslations":[]},{"id":1089054,"number":13,"endPoint":"Time to change of disease milestones","isPrimary":false,"endPointTranslations":[]}]},"trialDuration":{"estimatedGlobalEndDate":"2030-02-28","estimatedEndDate":"2030-02-28","estimatedRecruitmentStartDate":"2024-05-31"},"sourceOfMonetarySupport":[{"id":100815,"organisationName":"Sarepta Therapeutics, Inc."}],"populationOfTrialSubjects":{"ageRanges":[{"id":376841,"ageRangeCategoryCode":"3","ageRangeCategory":"3"},{"id":376842,"ageRangeCategoryCode":"2","ageRangeCategory":"2"},{"id":376843,"ageRangeCategoryCode":"4","ageRangeCategory":"4"}],"ageRangeSecondaryIds":[{"id":376848,"ageRangeCategoryCode":"4","ctAgeRangeCode":"8","ageRangeCategory":"4","ctAgeRange":"8"},{"id":376844,"ageRangeCategoryCode":"4","ctAgeRangeCode":"7","ageRangeCategory":"4","ctAgeRange":"7"},{"id":376847,"ageRangeCategoryCode":"2","ctAgeRangeCode":"6","ageRangeCategory":"2","ctAgeRange":"6"},{"id":376845,"ageRangeCategoryCode":"2","ctAgeRangeCode":"4","ageRangeCategory":"2","ctAgeRange":"4"},{"id":376846,"ageRangeCategoryCode":"2","ctAgeRangeCode":"5","ageRangeCategory":"2","ctAgeRange":"5"}],"clinicalTrialGroups":[{"code":"2","name":"Patients"}],"isFemaleSubjects":true,"isMaleSubjects":true,"isVulnerablePopulationSelected":true},"individualParticipantData":{"planToShareIPD":"3"}},"protocolInformation":{"studyDesign":{"periodDetails":[{"id":196385,"businessKey":"1","title":"Screening","description":"Screening will include confirmatory genetic testing and other screening assessments; maximum 31-day duration.","blindingMethodCode":"3","blindedRoles":[],"armDetails":[],"allocationMethod":"3"},{"id":196386,"businessKey":"2","title":"Lead-in Period","description":"The Lead-in period includes additional screening prior to the baseline assessments. The 6-month Lead-In Period prior to SRP-9003 infusion required for all subjects except for subjects who have completed ≥ 6 months in the SRP-LGMD-501-NHS (Journey; NCT04475926) or GRASP-01-001-NHS (NCT03981289), including at minimum 2 study assessment visits that are ≥ 6 months apart with functional assessments, and consented to have their natural history data shared for use in the SRP-9003-301 study. Subjects enrolled from the Journey or GRASP natural history study who meet the above natural history  criteria will progress from the -31-day Screening Period to the Baseline Period assessments per the SOE.\nThe Lead-In Period will include pre-treatment function and safety assessments","blindingMethodCode":"3","blindedRoles":[],"armDetails":[],"allocationMethod":"3"},{"id":196387,"businessKey":"3","title":"Baseline","description":"Prior to infusion, as per the SOE, a series of Baseline tests will be performed as described in the protocol; 1 day duration.","blindingMethodCode":"3","blindedRoles":[],"armDetails":[],"allocationMethod":"3"},{"id":196388,"businessKey":"4","title":"Infusion","description":"SRP-9003 will be delivered by the route of administration described in the protocol. Subjects will be administered a prophylactic glucocorticoid (prednisone or equivalent) to dampen the host immune response to adeno-associated virus (AAV) therapy starting approximately 24 hours prior to SRP-9003 infusion; 1-day duration","blindingMethodCode":"3","blindedRoles":[],"armDetails":[],"allocationMethod":"3"},{"id":196389,"businessKey":"5","title":"Follow-up","description":"The study will include a 60-month Follow-Up Period (post-infusion) during which safety and expression will be  evaluated. Physical functional assessments and immunogenicity will be assessed during this period.\nFor subjects who complete the study, the last study visit will occur at Month 60. For subjects who terminate the study early, an early termination visit will be required","blindingMethodCode":"3","blindedRoles":[],"armDetails":[],"allocationMethod":"3"}]}},"scientificAdviceAndPip":{"scientificAdvices":[{"id":59393,"competentAuthority":{"id":294034,"organisation":{"id":309884,"type":"Non-EEA National Competent authority","typeCode":"17","name":"Food And Drug Administration","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100006066","organisationLocationStatus":"Active"},"address":{"addressId":313749,"oneLine":"10903 New Hampshire Avenue","addressLine1":"10903 New Hampshire Avenue","addressLine2":"","addressLine3":"","addressLine4":"","city":"Silver Spring","postcode":"20903-1058","country":840,"countryName":"United States"},"isBusinessKeyValidated":true,"businessKey":"ORG-100006066"}},{"id":59394,"competentAuthority":{"id":293520,"organisation":{"id":306572,"type":"EU Institution/Body/Agency","typeCode":"14","name":"European Medicines Agency","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100013412","organisationLocationStatus":"Active"},"address":{"addressId":313185,"oneLine":"Domenico Scarlattilaan 6","addressLine1":"Domenico Scarlattilaan 6","addressLine2":"","addressLine3":"","addressLine4":"","city":"Amsterdam","postcode":"1083 HS","country":2029,"countryName":"Netherlands"},"isBusinessKeyValidated":true,"businessKey":"ORG-100013412"}}],"paediatricInvestigationPlan":[]},"associatedClinicalTrials":[],"references":[],"pubmedCode":[],"pubmedUrl":[]},"assessmentOutcome":"acceptable_conditions","assessmentOutcomeDate":"2026-06-05","conclusionDate":"2026-06-05","therapeuticAreas":[{"code":"5","name":"Diseases [C] - Musculoskeletal Diseases [C05]"}],"medicalConditions":[{"id":143480,"medicalCondition":"Limb-girdle muscular dystrophy, type 2E/R4 (LGMD2E/R4) or β-sarcoglycanopathy","isConditionRareDisease":true}],"sponsors":[{"id":156038,"primary":true,"publicContacts":[{"id":460581,"type":"Public","functionalName":"Patient Recruitment","functionalEmailAddress":"SareptAlly@sarepta.com","telephone":"+18887273782","organisation":{"id":70847,"type":"Pharmaceutical company","typeCode":"10","name":"Sarepta Therapeutics Inc.","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100006645","organisationLocationStatus":"Active"}}],"scientificContacts":[{"id":460582,"type":"Scientific","functionalName":"Patient Recruitment","functionalEmailAddress":"SareptAlly@sarepta.com","telephone":"+18887273782","organisation":{"id":70847,"type":"Pharmaceutical company","typeCode":"10","name":"Sarepta Therapeutics Inc.","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100006645","organisationLocationStatus":"Active"}}],"thirdParties":[{"id":710587,"organisationAddress":{"id":1003494,"organisation":{"id":1048691,"type":"Laboratory/Research/Testing facility","typeCode":"9","name":"Kps Life LLC","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100052008","organisationLocationStatus":"Active"},"address":{"addressId":1131401,"oneLine":"10 Valley Stream Parkway Suite 302","addressLine1":"10 Valley Stream Parkway Suite 302","addressLine2":"","addressLine3":"","addressLine4":"","city":"Malvern","postcode":"19355-1447","country":840,"countryName":"United States"},"phone":"18882301577","email":"info@kpslife.com","isBusinessKeyValidated":true,"businessKey":"LOC-100091472"},"sponsorDuties":[{"id":1102431,"code":"15","value":"Review of monitoring visit reports and monitoring oversight"}],"phoneNumber":"18882301577","email":"info@kpslife.com"},{"id":710574,"organisationAddress":{"id":294880,"organisation":{"id":317065,"type":"Pharmaceutical company","typeCode":"10","name":"Biotel Research LLC","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100039864","organisationLocationStatus":"Active"},"address":{"addressId":314658,"oneLine":"155 Corporate Woods Suite 180","addressLine1":"155 Corporate Woods Suite 180","addressLine2":"","addressLine3":"","addressLine4":"","city":"Rochester","postcode":"14623-1458","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100039864"},"sponsorDuties":[{"id":1102409,"code":"15","value":"Central ECG / Echo / MRI"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710566,"organisationAddress":{"id":294892,"organisation":{"id":317077,"type":"Pharmaceutical company","typeCode":"10","name":"Catalent Germany Schorndorf GmbH","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100011845","organisationLocationStatus":"Active"},"address":{"addressId":314670,"oneLine":"Steinbeisstrasse 1-2","addressLine1":"Steinbeisstrasse 1-2","addressLine2":"","addressLine3":"","addressLine4":"","city":"Schorndorf","postcode":"73614","country":2013,"countryName":"Germany"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100011845"},"sponsorDuties":[{"id":1102400,"code":"14"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710586,"organisationAddress":{"id":294879,"organisation":{"id":317064,"type":"Non-Pharmaceutical company","typeCode":"11","name":"Atom International Limited","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100042393","organisationLocationStatus":"Active"},"address":{"addressId":314657,"oneLine":"Unit 4, Earls House, Earlsway, Team Valley Trading Estate","addressLine1":"Unit 4","addressLine2":"Earls House","addressLine3":"Earlsway","addressLine4":"Team Valley Trading Estate","city":"Gateshead","postcode":"NE11 0RY","country":826,"countryName":"United Kingdom"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100042393"},"sponsorDuties":[{"id":1102430,"code":"15","value":"Clinical Evaluator Training"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710573,"organisationAddress":{"id":294951,"organisation":{"id":317136,"type":"Pharmaceutical company","typeCode":"10","name":"Matthews Media Group Inc.","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100045638","organisationLocationStatus":"Active"},"address":{"addressId":314737,"oneLine":"7361 Calhoun Place","addressLine1":"7361 Calhoun Place","addressLine2":"","addressLine3":"","addressLine4":"","city":"Derwood","postcode":"20855-2765","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100045638"},"sponsorDuties":[{"id":1102408,"code":"15","value":"Patient recruitment"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710583,"organisationAddress":{"id":294890,"organisation":{"id":317075,"type":"Non-Pharmaceutical company","typeCode":"11","name":"4g Clinical LLC","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100042775","organisationLocationStatus":"Active"},"address":{"addressId":314668,"oneLine":"370 Washington Street","addressLine1":"370 Washington Street","addressLine2":"","addressLine3":"","addressLine4":"","city":"Wellesley","postcode":"02481-6207","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100042775"},"sponsorDuties":[{"id":1102420,"code":"3"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710569,"organisationAddress":{"id":294885,"organisation":{"id":317070,"type":"Pharmaceutical company","typeCode":"10","name":"Signant Health Global Solutions Limited","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100047290","organisationLocationStatus":"Active"},"address":{"addressId":314663,"oneLine":"10 Earlsfort Terrace","addressLine1":"10 Earlsfort Terrace","addressLine2":"","addressLine3":"","addressLine4":"","city":"Dublin 2","postcode":"D02 T380","country":2017,"countryName":"Ireland"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100047290"},"sponsorDuties":[{"id":1102403,"code":"7"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710580,"organisationAddress":{"id":294968,"organisation":{"id":317153,"type":"Pharmaceutical company","typeCode":"10","name":"United Biosource LLC","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100027856","organisationLocationStatus":"Active"},"address":{"addressId":314754,"oneLine":"920 Harvest Drive","addressLine1":"920 Harvest Drive","addressLine2":"","addressLine3":"","addressLine4":"","city":"Blue Bell","postcode":"19422-1968","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100027856"},"sponsorDuties":[{"id":1102417,"code":"15","value":"Pharmacovigilance"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710568,"organisationAddress":{"id":294882,"organisation":{"id":317067,"type":"Non-Pharmaceutical company","typeCode":"11","name":"Longboat Clinical Limited","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100045828","organisationLocationStatus":"Active"},"address":{"addressId":314660,"oneLine":"Unit 4, Castletroy Business Park, Plassey Park Road, Castletroy","addressLine1":"Unit 4","addressLine2":"Castletroy Business Park","addressLine3":"Plassey Park Road","addressLine4":"Castletroy","city":"Limerick","postcode":"V94 AE77","country":2017,"countryName":"Ireland"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100045828"},"sponsorDuties":[{"id":1102402,"code":"15","value":"Site portal"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710570,"organisationAddress":{"id":294887,"organisation":{"id":317072,"type":"Pharmaceutical company","typeCode":"10","name":"Sysnav","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100026890","organisationLocationStatus":"Active"},"address":{"addressId":314665,"oneLine":"72 Rue Emile Loubet","addressLine1":"72 Rue Emile Loubet","addressLine2":"","addressLine3":"","addressLine4":"","city":"Vernon","postcode":"27200","country":2012,"countryName":"France"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100026890"},"sponsorDuties":[{"id":1102404,"code":"15","value":"Wearable activity tracker"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710581,"organisationAddress":{"id":294884,"organisation":{"id":317069,"type":"Laboratory/Research/Testing facility","typeCode":"9","name":"Professional Case Management Clinical Trials LLC","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100044408","organisationLocationStatus":"Active"},"address":{"addressId":314662,"oneLine":"500 East 8th Avenue","addressLine1":"500 East 8th Avenue","addressLine2":"","addressLine3":"","addressLine4":"","city":"Denver","postcode":"80203-3716","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100044408"},"sponsorDuties":[{"id":1102418,"code":"15","value":"Home Health Care"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710576,"organisationAddress":{"id":294970,"organisation":{"id":317155,"type":"Pharmaceutical company","typeCode":"10","name":"Cellular Technology Ltd.","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100046556","organisationLocationStatus":"Active"},"address":{"addressId":314756,"oneLine":"20521 Chagrin Boulevard","addressLine1":"20521 Chagrin Boulevard","addressLine2":"","addressLine3":"","addressLine4":"","city":"Shaker Heights","postcode":"44122-5350","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100046556"},"sponsorDuties":[{"id":1102411,"code":"15","value":"T-cell immune response (ELISPOT)"},{"id":1102412,"code":"4"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710577,"organisationAddress":{"id":294889,"organisation":{"id":317074,"type":"Laboratory/Research/Testing facility","typeCode":"9","name":"Athena Diagnostics Inc.","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100048388","organisationLocationStatus":"Active"},"address":{"addressId":314667,"oneLine":"200 Forest Street","addressLine1":"200 Forest Street","addressLine2":"","addressLine3":"","addressLine4":"","city":"Marlborough","postcode":"01752-3023","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100048388"},"sponsorDuties":[{"id":1102413,"code":"4"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710575,"organisationAddress":{"id":294886,"organisation":{"id":317071,"type":"Pharmaceutical company","typeCode":"10","name":"Vitalograph Limited","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100039692","organisationLocationStatus":"Active"},"address":{"addressId":314664,"oneLine":"Maids Moreton House, Vitalograph Business Park, Maids Moreton","addressLine1":"Maids Moreton House","addressLine2":"Vitalograph Business Park","addressLine3":"Maids Moreton","addressLine4":"","city":"Buckingham","postcode":"MK18 1SW","country":826,"countryName":"United Kingdom"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100039692"},"sponsorDuties":[{"id":1102410,"code":"13"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710571,"organisationAddress":{"id":294971,"organisation":{"id":317156,"type":"Pharmaceutical company","typeCode":"10","name":"Chillibean Limited","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100042592","organisationLocationStatus":"Active"},"address":{"addressId":314758,"oneLine":"3rd Floor, 55 New Oxford Street","addressLine1":"3rd Floor","addressLine2":"55 New Oxford Street","addressLine3":"","addressLine4":"","city":"London","postcode":"WC1A 1BS","country":826,"countryName":"United Kingdom"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100042592"},"sponsorDuties":[{"id":1102405,"code":"13"},{"id":1102406,"code":"15","value":"filming of the clincial assessments and evaluation"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710567,"organisationAddress":{"id":294881,"organisation":{"id":317066,"type":"Non-Pharmaceutical company","typeCode":"11","name":"Greenphire LLC","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100041621","organisationLocationStatus":"Active"},"address":{"addressId":314659,"oneLine":"1018 West 9th Avenue Suite 200","addressLine1":"1018 West 9th Avenue Suite 200","addressLine2":"","addressLine3":"","addressLine4":"","city":"King Of Prussia","postcode":"19406-1225","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100041621"},"sponsorDuties":[{"id":1102401,"code":"15","value":"Patient Reimbursement"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710579,"organisationAddress":{"id":294883,"organisation":{"id":317068,"type":"Non-Pharmaceutical company","typeCode":"11","name":"Medidata Solutions Inc.","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100016256","organisationLocationStatus":"Active"},"address":{"addressId":314661,"oneLine":"350 Hudson Street","addressLine1":"350 Hudson Street","addressLine2":"","addressLine3":"","addressLine4":"","city":"New York","postcode":"10014-4504","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100016256"},"sponsorDuties":[{"id":1102416,"code":"6"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710572,"organisationAddress":{"id":294888,"organisation":{"id":317073,"type":"Laboratory/Research/Testing facility","typeCode":"9","name":"Perkinelmer Genetics Inc.","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100047426","organisationLocationStatus":"Active"},"address":{"addressId":314666,"oneLine":"250 Industry Drive","addressLine1":"250 Industry Drive","addressLine2":"","addressLine3":"","addressLine4":"","city":"Pittsburgh","postcode":"15275-1017","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100047426"},"sponsorDuties":[{"id":1102407,"code":"4"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710578,"organisationAddress":{"id":294969,"organisation":{"id":317154,"type":"Pharmaceutical company","typeCode":"10","name":"Bioagilytix Labs LLC","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100013030","organisationLocationStatus":"Active"},"address":{"addressId":314755,"oneLine":"2300 Englert Drive Suite G","addressLine1":"2300 Englert Drive Suite G","addressLine2":"","addressLine3":"","addressLine4":"","city":"Durham","postcode":"27713-4450","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100013030"},"sponsorDuties":[{"id":1102414,"code":"15","value":"specilalized lab - biomarkers"},{"id":1102415,"code":"4"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710582,"organisationAddress":{"id":294964,"organisation":{"id":317149,"type":"Health care","typeCode":"2","name":"Sarepta GTCOE","commercial":false,"isBusinessKeyValidated":false,"businessKey":"ORL-000004500","organisationLocationStatus":"Active"},"address":{"addressId":314750,"oneLine":"4201 Easton Commons","addressLine1":"4201 Easton Commons","addressLine2":"","addressLine3":"","addressLine4":"","city":"Columbus","postcode":"43219","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":false,"businessKey":"ORL-000004500"},"sponsorDuties":[{"id":1102419,"code":"4"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710584,"organisationAddress":{"id":294891,"organisation":{"id":317076,"type":"Pharmaceutical company","typeCode":"10","name":"Biopier Inc.","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100049989","organisationLocationStatus":"Active"},"address":{"addressId":314669,"oneLine":"80 Blanchard Road Suite 104","addressLine1":"80 Blanchard Road Suite 104","addressLine2":"","addressLine3":"","addressLine4":"","city":"Burlington","postcode":"01803-5208","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100049989"},"sponsorDuties":[{"id":1102421,"code":"10"}],"phoneNumber":"0000","email":"xxx@xxx.com"},{"id":710585,"organisationAddress":{"id":294878,"organisation":{"id":317063,"type":"Pharmaceutical company","typeCode":"10","name":"PPD Development LP","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100011560","organisationLocationStatus":"Active"},"address":{"addressId":314656,"oneLine":"3151 South 17th Street","addressLine1":"3151 South 17th Street","addressLine2":"","addressLine3":"","addressLine4":"","city":"Wilmington","postcode":"28412-6461","country":840,"countryName":"United States"},"phone":"0000","email":"xxx@xxx.com","isBusinessKeyValidated":true,"businessKey":"ORG-100011560"},"sponsorDuties":[{"id":1102422,"code":"1"},{"id":1102423,"code":"12"},{"id":1102424,"code":"13"},{"id":1102425,"code":"14"},{"id":1102426,"code":"4"},{"id":1102427,"code":"5"},{"id":1102428,"code":"6"},{"id":1102429,"code":"7"}],"phoneNumber":"0000","email":"xxx@xxx.com"}],"organisation":{"id":70847,"type":"Pharmaceutical company","typeCode":"10","name":"Sarepta Therapeutics Inc.","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100006645","organisationLocationStatus":"Active"},"addresses":[{"id":68492,"organisation":{"id":70847,"type":"Pharmaceutical company","typeCode":"10","name":"Sarepta Therapeutics Inc.","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100006645","organisationLocationStatus":"Active"},"address":{"addressId":71431,"oneLine":"215 1st Street","addressLine1":"215 1st Street","addressLine2":"","addressLine3":"","addressLine4":"","city":"Cambridge","postcode":"02142-1213","country":840,"countryName":"United States"},"isBusinessKeyValidated":true,"businessKey":"LOC-100013341"}],"isCommercial":true,"commercial":"Commercial"}],"trialCategoryCode":"2","trialCategoryJustificationComment":"According to the \"Appendix on transparency rules to the functional specifications of the EU clinical trials portal and database\" chapter 4.3.3, Category 2 trials are safety and efficacy trials in patients, and include phase III trials carried out to investigate the safety and efficacy of the investigational medicinal product. The current study meets this requirement, as SRP-9003-301 is a Phase III study conducted to Investigate the Efficacy and Safety of SRP-9003 in Subjects with Limb Girdle Muscular Dystrophy 2E/R4","partOneTherapeuticAreas":[{"id":1202560,"therapeuticArea":{"code":"5","name":"Diseases [C] - Musculoskeletal Diseases [C05]"}}],"productRoleGroupInfos":[{"id":424733,"comments":"SRP-9003","productRoleCode":"1","productRoleName":"Test","products":[{"id":570848,"part1MpRoleTypeCode":"1","productDictionaryInfo":{"productPk":"10893265","productPharmForm":"VIAL FOR INTRAVENOUS USE","euMpNumber":"PRD10893265","prodAuthStatus":1,"prodName":"SRP-9003","pharmForm":"VIAL FOR INTRAVENOUS USE","sponsorProductCode":"SRP-9003","activeSubstanceName":"BIDRIDISTROGENE XEBOPARVOVEC","euSubstNumber":"SUB207366","nameOrg":"SAREPTA THERAPEUTICS INC","productSubstances":[{"productPk":"10893265","substancePk":"339860","nameOrg":"SAREPTA THERAPEUTICS INC","substanceOrigin":"Structurally Diverse Substance - Other","actSubstOrigin":"Structurally Diverse Substance - Other","actSubstName":"BIDRIDISTROGENE XEBOPARVOVEC","substanceEvCode":"SUB207366"}],"activeSubstanceOtherDescriptiveName":""},"isPaediatricFormulation":false,"mpRoleInTrial":"1","orphanDrugEdit":true,"orphanDrugDesigNumber":"EU/3/20/2365","doseUom":"DF dosage form","maxDailyDoseAmount":"74100000000000","doseUomTotal":"DF dosage form","maxTotalDoseAmount":"74100000000000","maxTreatmentPeriod":60,"timeUnitCode":"3","otherMedicinalProduct":"Containing GMO(s)","evCode":"PRD10893265","sponsorProductCodeEdit":"SRP-9003","therapies":[{"id":7372,"advancedTherapyType":"3","geneOfInterest":"β-sarcoglycan","description":"recombinant AAV","isInVivo":true,"geneTransferProductType":"3"}],"devices":[],"characteristics":["11","7"],"routes":["INTRAVENIOUS INFUSION"],"allSubstancesChemicals":false,"productName":"SRP-9003","jsonActiveSubstanceNames":"bidridistrogene xeboparvovec","pharmaceuticalFormDisplay":"VIAL FOR INTRAVENOUS USE"}]},{"id":424732,"comments":"PREDNISONE, PREDNISONE, PREDNISONE","productRoleCode":"4","productRoleName":"Auxiliary","products":[{"id":570845,"part1MpRoleTypeCode":"3","productDictionaryInfo":{"euMpNumber":"SUB10020MIG","marketingAuthNumber":"-","prodAuthStatus":2,"prodName":"PREDNISONE","pharmForm":"TABLET","activeSubstanceName":"PREDNISONE","euSubstNumber":"SUB10020MIG","productSubstances":[{"substancePk":"173026","actSubstOrigin":"Chemical","actSubstName":"PREDNISONE","substanceEvCode":"SUB10020MIG"}],"atcCode":"-","atcName":"-","atcTermLevel":"-","activeSubstanceOtherDescriptiveName":"prednisone or equivalent"},"isPaediatricFormulation":false,"mpRoleInTrial":"4","orphanDrugEdit":false,"doseUom":"mg milligram(s)","maxDailyDoseAmount":"60","doseUomTotal":"mg milligram(s)","maxTotalDoseAmount":"60","productChangedRelationMA":false,"maxTreatmentPeriod":12,"timeUnitCode":"2","otherMedicinalProduct":"Anti-inflamatory properties similar to other corticoids","scientificProductEvCode":"SUB10020MIG","devices":[],"characteristics":["11"],"routes":["ORAL"],"allSubstancesChemicals":false,"productName":"PREDNISONE","jsonActiveSubstanceNames":"prednisone"},{"id":570846,"part1MpRoleTypeCode":"3","productDictionaryInfo":{"euMpNumber":"SUB10020MIG","marketingAuthNumber":"-","prodAuthStatus":2,"prodName":"PREDNISONE","pharmForm":"TABLET","activeSubstanceName":"PREDNISONE","euSubstNumber":"SUB10020MIG","productSubstances":[{"substancePk":"172490","actSubstOrigin":"Chemical","actSubstName":"PREDNISONE","substanceEvCode":"SUB10020MIG"}],"atcCode":"-","atcName":"-","atcTermLevel":"-","activeSubstanceOtherDescriptiveName":"prednisone or equivalent"},"isPaediatricFormulation":false,"mpRoleInTrial":"4","orphanDrugEdit":false,"doseUom":"mg milligram(s)","maxDailyDoseAmount":"60","doseUomTotal":"mg milligram(s)","maxTotalDoseAmount":"60","productChangedRelationMA":false,"maxTreatmentPeriod":12,"timeUnitCode":"2","otherMedicinalProduct":"Anti-inflamatory properties similar to other corticoids","scientificProductEvCode":"SUB10020MIG","devices":[],"characteristics":["11"],"routes":["ORAL"],"allSubstancesChemicals":false,"productName":"PREDNISONE","jsonActiveSubstanceNames":"prednisone"},{"id":570847,"part1MpRoleTypeCode":"3","productDictionaryInfo":{"euMpNumber":"SUB10020MIG","marketingAuthNumber":"-","prodAuthStatus":2,"prodName":"PREDNISONE","pharmForm":"TABLET","activeSubstanceName":"PREDNISONE","euSubstNumber":"SUB10020MIG","productSubstances":[{"substancePk":"71836","actSubstOrigin":"Chemical","actSubstName":"PREDNISONE","substanceEvCode":"SUB10020MIG"}],"atcCode":"-","atcName":"-","atcTermLevel":"-","activeSubstanceOtherDescriptiveName":"prednisone or equivalent"},"isPaediatricFormulation":false,"mpRoleInTrial":"4","orphanDrugEdit":false,"doseUom":"mg milligram(s)","maxDailyDoseAmount":"60","doseUomTotal":"mg milligram(s)","maxTotalDoseAmount":"60","productChangedRelationMA":false,"maxTreatmentPeriod":12,"timeUnitCode":"2","otherMedicinalProduct":"Anti-inflamatory properties similar to other corticoids","scientificProductEvCode":"SUB10020MIG","devices":[],"characteristics":["11"],"routes":["ORAL"],"allSubstancesChemicals":false,"productName":"PREDNISONE","jsonActiveSubstanceNames":"prednisone"}]}],"isLowIntervention":false},"authorizedPartsII":[{"id":83976,"mscId":20985,"mscInfo":{"id":20985,"clinicalTrialId":3314,"countryOrganisationId":2027,"reportingStatusCode":"Ended","fromDate":"2024-03-26","toDate":"2024-03-26","isProposedRms":false,"expressDecision":"unwilling","countryName":"Spain","organisationInfo":{},"firstDecisionDate":"2024-06-10","trialStatus":"Ended","trialPeriod":[{"id":40497,"trialStartDate":"2024-10-23","fromDate":"2024-10-30"},{"id":40498,"trialStartDate":"2024-10-23","fromDate":"2024-10-30"},{"id":47352,"trialStartDate":"2024-10-23","trialEndDate":"2024-12-16","fromDate":"2025-01-07"}],"trialRecruitmentPeriod":[],"hasRecruitmentStarted":false,"activeTrialPeriod":{"id":65392,"trialStartDate":"2024-10-23","trialEndDate":"2024-12-16","fromDate":"2024-10-30","isBenefitRiskBalanceTemporaryHalt":false,"isBenefitRiskBalanceEndTrail":false,"isTemporaryHalt":false,"isEndTrial":true},"activeTrialRecruitmentPeriod":{},"isWillingAtDayThreeView":false,"clinicalTrialStatusHistory":[{"id":19776,"mscId":20985,"trialStatus":"Under evaluation","trialStatusDate":"2023-12-22T13:14:29.725"},{"id":37796,"mscId":20985,"trialStatus":"Authorised","trialStatusDate":"2024-06-10T09:34:10.959"},{"id":73290,"mscId":20985,"trialStatus":"Ended","trialStatusDate":"2025-01-07T14:51:58.366"}],"applicationTypeMsc":"1","mscName":"Spain","assessmentOutcome":"acceptable","assessmentOutcomeDate":"2024-04-22","decision":"authorized_conditions","decisionDate":"2024-06-10"},"decisionDate":"2024-06-10","recruitmentSubjectCount":2,"trialSites":[{"id":545232,"organisationAddressInfo":{"id":292760,"organisation":{"id":302742,"type":"Hospital/Clinic/Other health care facility","typeCode":"8","name":"Sant Joan De Deu Barcelona Hospital","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100023083","organisationLocationStatus":"Active"},"address":{"addressId":312346,"oneLine":"Passeig De Sant Joan De Deu 2","addressLine1":"Passeig De Sant Joan De Deu 2","addressLine2":"","addressLine3":"","addressLine4":"","city":"Esplugues De Llobregat","postcode":"08950","country":2027,"countryName":"Spain"},"phone":"+34936009733","email":"carlos.ortez@sjd.es","isBusinessKeyValidated":true,"businessKey":"ORG-100023083"},"personInfo":{"id":614132,"firstName":"Carlos Ignacio","lastName":"Ortez González","telephone":"+34936009733","email":"carlos.ortez@sjd.es","title":"1"},"departmentName":"Neurology"}],"applicationStatusCode":"Authorised"},{"id":125946,"mscId":20990,"mscInfo":{"id":20990,"clinicalTrialId":3314,"countryOrganisationId":2013,"reportingStatusCode":"Ended","fromDate":"2024-03-25","toDate":"2024-03-25","isProposedRms":false,"expressDecision":"unwilling","countryName":"Germany","organisationInfo":{},"firstDecisionDate":"2024-06-06","trialStatus":"Ended","trialPeriod":[{"id":40495,"trialStartDate":"2024-10-21","fromDate":"2024-10-30"},{"id":40496,"trialStartDate":"2024-10-21","fromDate":"2024-10-30"},{"id":47350,"trialStartDate":"2024-10-21","trialEndDate":"2024-12-16","fromDate":"2025-01-07"}],"trialRecruitmentPeriod":[],"hasRecruitmentStarted":false,"activeTrialPeriod":{"id":65390,"trialStartDate":"2024-10-21","trialEndDate":"2024-12-16","fromDate":"2024-10-30","isBenefitRiskBalanceTemporaryHalt":false,"isBenefitRiskBalanceEndTrail":false,"isTemporaryHalt":false,"isEndTrial":true},"activeTrialRecruitmentPeriod":{},"isWillingAtDayThreeView":false,"clinicalTrialStatusHistory":[{"id":19774,"mscId":20990,"trialStatus":"Under evaluation","trialStatusDate":"2023-12-22T13:14:29.667"},{"id":37393,"mscId":20990,"trialStatus":"Authorised","trialStatusDate":"2024-06-06T13:32:24.619"},{"id":73289,"mscId":20990,"trialStatus":"Ended","trialStatusDate":"2025-01-07T14:51:13.276"}],"applicationTypeMsc":"1","mscName":"Germany","decision":"authorized_conditions","decisionDate":"2024-06-06"},"decisionDate":"2024-06-06","recruitmentSubjectCount":2,"trialSites":[{"id":826938,"organisationAddressInfo":{"id":292449,"organisation":{"id":301052,"type":"Educational Institution","typeCode":"1","name":"Justus-Liebig-Universitaet Giessen","commercial":true,"isBusinessKeyValidated":true,"businessKey":"ORG-100028650","organisationLocationStatus":"Active"},"address":{"addressId":312014,"oneLine":"Feulgenstrasse 10-12","addressLine1":"Feulgenstrasse 10-12","addressLine2":"","addressLine3":"","addressLine4":"","city":"Giessen","postcode":"35392","country":2013,"countryName":"Germany"},"phone":"+4964198543481","email":"andreas.hahn@paediat.med.uni-giessen.de","isBusinessKeyValidated":true,"businessKey":"ORG-100028650"},"personInfo":{"id":922626,"firstName":"Andreas","lastName":"Hahn","telephone":"+4964198543481","email":"andreas.hahn@paediat.med.uni-giessen.de","title":"2"},"departmentName":"Zentrum für Kinderheilkunde und Jugendmedizin"},{"id":826939,"organisationAddressInfo":{"id":292565,"organisation":{"id":301826,"type":"Hospital/Clinic/Other health care facility","typeCode":"8","name":"Universitaetsklinikum Essen AöR","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100009964","organisationLocationStatus":"Active"},"address":{"addressId":312136,"oneLine":"Hufelandstrasse 55, Holsterhausen","addressLine1":"Hufelandstrasse 55","addressLine2":"Holsterhausen","addressLine3":"","addressLine4":"","city":"Essen","postcode":"45147","country":2013,"countryName":"Germany"},"phone":"+4920172384601","email":"heike.koelbel@uk-essen.de","isBusinessKeyValidated":true,"businessKey":"ORG-100009964"},"personInfo":{"id":922627,"firstName":"Heike","lastName":"Koelbel","telephone":"+4920172384601","email":"heike.koelbel@uk-essen.de","title":"1"},"departmentName":"Klinik für Kinderheilkunde I, Sozialpädiatrisches Zentrum (SPZ)"}],"applicationStatusCode":"Authorised"},{"id":306328,"mscId":21030,"mscInfo":{"id":21030,"clinicalTrialId":3314,"countryOrganisationId":2002,"reportingStatusCode":"Authorised","fromDate":"2024-03-29","toDate":"2024-03-29","isProposedRms":true,"expressDecision":"willing","countryName":"Belgium","organisationInfo":{},"firstDecisionDate":"2024-06-03","trialStatus":"Authorised","trialPeriod":[{"id":40493,"trialStartDate":"2024-10-17","fromDate":"2024-10-30"},{"id":40494,"trialStartDate":"2024-10-17","fromDate":"2024-10-30"},{"id":40657,"trialStartDate":"2024-10-16","fromDate":"2024-10-30"}],"trialRecruitmentPeriod":[{"id":53188,"recruitmentStartDate":"2024-10-17","fromDate":"2024-10-30"},{"id":53189,"recruitmentStartDate":"2024-10-17","fromDate":"2024-10-30"},{"id":62811,"recruitmentStartDate":"2024-10-17","recruitmentEndDate":"2024-12-16","fromDate":"2025-01-07"},{"id":62812,"recruitmentStartDate":"2024-10-17","recruitmentEndDate":"2024-12-16","fromDate":"2025-01-07"}],"hasRecruitmentStarted":true,"activeTrialPeriod":{"id":54882,"trialStartDate":"2024-10-16","fromDate":"2024-10-30"},"activeTrialRecruitmentPeriod":{"recruitmentStartDate":"2024-10-17","recruitmentEndDate":"2024-12-16"},"isWillingAtDayThreeView":true,"clinicalTrialStatusHistory":[{"id":19773,"mscId":21030,"trialStatus":"Under evaluation","trialStatusDate":"2023-12-22T13:14:29.635"},{"id":36926,"mscId":21030,"trialStatus":"Authorised","trialStatusDate":"2024-06-03T15:51:33.031"}],"applicationTypeMsc":"1","mscName":"Belgium","assessmentOutcome":"acceptable","assessmentOutcomeDate":"2026-06-03","decision":"authorized_conditions","decisionDate":"2024-06-03"},"decisionDate":"2024-06-03","recruitmentSubjectCount":2,"trialSites":[{"id":2130397,"organisationAddressInfo":{"id":294147,"organisation":{"id":310678,"type":"Hospital/Clinic/Other health care facility","typeCode":"8","name":"Universitair Ziekenhuis Gent","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100021542","organisationLocationStatus":"Active"},"address":{"addressId":313866,"oneLine":"Corneel Heymanslaan 10","addressLine1":"Corneel Heymanslaan 10","addressLine2":"","addressLine3":"","addressLine4":"","city":"Gent","postcode":"9000","country":2002,"countryName":"Belgium"},"phone":"+3293324544","email":"jan.debleecker@ugent.be","isBusinessKeyValidated":true,"businessKey":"ORG-100021542"},"personInfo":{"id":2364000,"firstName":"Jan","lastName":"De Bleecker","telephone":"+3293324544","email":"jan.debleecker@ugent.be","title":"1"},"departmentName":"Neuromusculair referentiecentrum"},{"id":2130398,"organisationAddressInfo":{"id":294162,"organisation":{"id":310693,"type":"Hospital/Clinic/Other health care facility","typeCode":"8","name":"UZ Leuven","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100006001","organisationLocationStatus":"Active"},"address":{"addressId":313881,"oneLine":"Herestraat 49","addressLine1":"Herestraat 49","addressLine2":"","addressLine3":"","addressLine4":"","city":"Leuven","postcode":"3000","country":2002,"countryName":"Belgium"},"phone":"+3216344278","email":"kristl.claeys@uzleuven.be","isBusinessKeyValidated":true,"businessKey":"ORG-100006001"},"personInfo":{"id":2364001,"firstName":"Kristl","lastName":"Claeys","telephone":"+3216344278","email":"kristl.claeys@uzleuven.be","title":"1"},"departmentName":"Neurology"}],"applicationStatusCode":"Authorised"},{"id":304271,"mscId":21031,"mscInfo":{"id":21031,"clinicalTrialId":3314,"countryOrganisationId":2018,"reportingStatusCode":"Authorised","fromDate":"2024-04-10","toDate":"2024-04-10","isProposedRms":false,"expressDecision":"unwilling","countryName":"Italy","organisationInfo":{},"firstDecisionDate":"2024-06-07","trialStatus":"Authorised","trialPeriod":[{"id":43954,"trialStartDate":"2024-11-19","fromDate":"2024-11-26"},{"id":43955,"trialStartDate":"2024-11-19","fromDate":"2024-11-26"}],"trialRecruitmentPeriod":[{"id":95390,"recruitmentStartDate":"2025-05-14","recruitmentEndDate":"2025-05-14","fromDate":"2025-12-11"},{"id":95391,"recruitmentStartDate":"2025-05-14","recruitmentEndDate":"2025-05-14","fromDate":"2025-12-11"},{"id":94999,"recruitmentStartDate":"2025-05-14","fromDate":"2025-12-08"},{"id":95000,"recruitmentStartDate":"2025-05-14","fromDate":"2025-12-08"},{"id":95001,"recruitmentStartDate":"2025-05-14","recruitmentEndDate":"2025-05-14","fromDate":"2025-12-08"},{"id":95002,"recruitmentStartDate":"2025-05-14","recruitmentEndDate":"2025-05-14","fromDate":"2025-12-08"},{"id":95147,"recruitmentStartDate":"2025-05-14","fromDate":"2025-12-09"},{"id":95148,"recruitmentStartDate":"2025-05-14","fromDate":"2025-12-09"},{"id":95100,"recruitmentStartDate":"2025-05-14","fromDate":"2025-12-09"},{"id":95149,"recruitmentStartDate":"2025-05-14","recruitmentEndDate":"2025-05-14","fromDate":"2025-12-09"}],"hasRecruitmentStarted":true,"activeTrialPeriod":{"id":59845,"trialStartDate":"2024-11-19","fromDate":"2024-11-26"},"activeTrialRecruitmentPeriod":{"recruitmentStartDate":"2025-05-14","recruitmentEndDate":"2025-05-14"},"isWillingAtDayThreeView":false,"clinicalTrialStatusHistory":[{"id":19775,"mscId":21031,"trialStatus":"Under evaluation","trialStatusDate":"2023-12-22T13:14:29.698"},{"id":37577,"mscId":21031,"trialStatus":"Authorised","trialStatusDate":"2024-06-07T11:31:03.816"}],"applicationTypeMsc":"1","mscName":"Italy","assessmentOutcome":"acceptable","assessmentOutcomeDate":"2026-06-04","decision":"authorized_conditions","decisionDate":"2024-06-07"},"decisionDate":"2024-06-07","recruitmentSubjectCount":2,"trialSites":[{"id":2115596,"organisationAddressInfo":{"id":293522,"organisation":{"id":306574,"type":"Hospital/Clinic/Other health care facility","typeCode":"8","name":"Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100006307","organisationLocationStatus":"Active"},"address":{"addressId":313187,"oneLine":"Via Francesco Sforza 35","addressLine1":"Via Francesco Sforza 35","addressLine2":"","addressLine3":"","addressLine4":"","city":"Milan","postcode":"20122","country":2018,"countryName":"Italy"},"phone":"+390255033802","email":"giacomo.comi@unimi.it","isBusinessKeyValidated":true,"businessKey":"ORG-100006307"},"personInfo":{"id":2347737,"firstName":"Giacomo","lastName":"Comi","telephone":"+390255033802","email":"giacomo.comi@unimi.it","title":"2"},"departmentName":"U.O. Neurologia -Malattie Neurodegenerative"}],"applicationStatusCode":"Authorised"}],"applicationInfo":[{"id":4036,"type":"INITIAL","status":"Authorised","ctNumber":"2022-503112-17-00","trialStatus":"Authorised","submissionDate":"2023-12-22","partI":{"assessmentOutcome":"acceptable_conditions","assessmentOutcomeDate":"2024-06-03"},"partIIInfo":[{"id":85105,"mscId":21030,"mscInfo":{"id":21030,"mscName":"Belgium","countryOrganisationId":2002,"assessmentOutcome":"acceptable_conditions","assessmentOutcomeDate":"2024-04-22","decision":"authorized_conditions","decisionDate":"2024-06-03","reportingStatusCode":"Authorised","countryName":"Belgium","trialStatus":"Authorised","firstDecisionDate":"2024-06-03"},"applicationStatusCode":"Authorised"},{"id":87907,"mscId":21031,"mscInfo":{"id":21031,"mscName":"Italy","countryOrganisationId":2018,"assessmentOutcome":"acceptable","assessmentOutcomeDate":"2024-04-22","decision":"authorized_conditions","decisionDate":"2024-06-07","reportingStatusCode":"Authorised","countryName":"Italy","trialStatus":"Authorised","firstDecisionDate":"2024-06-07"},"applicationStatusCode":"Authorised"},{"id":83810,"mscId":20990,"mscInfo":{"id":20990,"mscName":"Germany","countryOrganisationId":2013,"assessmentOutcome":"acceptable_conditions","assessmentOutcomeDate":"2024-04-22","decision":"authorized_conditions","decisionDate":"2024-06-06","reportingStatusCode":"Ended","countryName":"Germany","trialStatus":"Ended","firstDecisionDate":"2024-06-06"},"applicationStatusCode":"Authorised"},{"id":83976,"mscId":20985,"mscInfo":{"id":20985,"mscName":"Spain","countryOrganisationId":2027,"assessmentOutcome":"acceptable","assessmentOutcomeDate":"2024-04-22","decision":"authorized_conditions","decisionDate":"2024-06-10","reportingStatusCode":"Ended","countryName":"Spain","trialStatus":"Ended","firstDecisionDate":"2024-06-10"},"applicationStatusCode":"Authorised"}],"decisionDate":"2024-06-03","ctMSCsByApplication":[{"id":21030,"mscName":"Belgium","reportingStatusCode":"Authorised"},{"id":21031,"mscName":"Italy","reportingStatusCode":"Authorised"},{"id":20990,"mscName":"Germany","reportingStatusCode":"Ended"},{"id":20985,"mscName":"Spain","reportingStatusCode":"Ended"}],"businessKey":"IN","allPartTwosOutOfScope":false,"applicationTrialDecisionByMsc":{},"decisions":[{"id":24445,"applicationId":4036,"mscId":20985,"mscName":"Spain","decisionDate":"2024-06-10T09:34:12.202","decision":"authorized_conditions","assessmentOutcome":"acceptable","eventType":"decision","part2Id":83976,"part1Id":38943,"applicationType":"INITIAL","isRMS":false},{"id":24239,"applicationId":4036,"mscId":20990,"mscName":"Germany","decisionDate":"2024-06-06T13:32:25.682","decision":"authorized_conditions","assessmentOutcome":"acceptable_conditions","eventType":"decision","part2Id":83810,"part1Id":38943,"applicationType":"INITIAL","isRMS":false},{"id":23746,"applicationId":4036,"mscId":21030,"mscName":"Belgium","decisionDate":"2024-06-03T15:51:34.327","decision":"authorized_conditions","assessmentOutcome":"acceptable_conditions","eventType":"decision","part2Id":85105,"part1Id":38943,"applicationType":"INITIAL","isRMS":true},{"id":24328,"applicationId":4036,"mscId":21031,"mscName":"Italy","decisionDate":"2024-06-07T11:31:04.982","decision":"authorized_conditions","assessmentOutcome":"acceptable","eventType":"decision","part2Id":87907,"part1Id":38943,"applicationType":"INITIAL","isRMS":false}]},{"id":32760,"type":"NON SUBSTANTIAL MODIFICATION","status":"Authorised","ctNumber":"2022-503112-17-00","trialStatus":"Authorised","submissionDate":"2024-08-06","partI":{"assessmentOutcome":"acceptable_conditions","assessmentOutcomeDate":"2024-06-03"},"partIIInfo":[{"id":125946,"mscId":20990,"mscInfo":{"id":20990,"mscName":"Germany","countryOrganisationId":2013,"decision":"authorized_conditions","decisionDate":"2024-06-06","reportingStatusCode":"Ended","countryName":"Germany","trialStatus":"Ended","firstDecisionDate":"2024-06-06"},"applicationStatusCode":"Authorised"}],"decisionDate":"2024-08-06","ctMSCsByApplication":[{"id":20990,"mscName":"Germany","reportingStatusCode":"Ended"}],"businessKey":"NSM-1","modScope":"PART_II","allPartTwosOutOfScope":false,"applicationTrialDecisionByMsc":{},"decisions":[{"id":32575,"applicationId":32760,"mscId":20990,"mscName":"Germany","decisionDate":"2024-08-06T22:01:20.456","decision":"authorized","eventType":"decision","part2Id":125946,"part1Id":49850,"applicationType":"NON SUBSTANTIAL MODIFICATION","isRMS":false}]},{"id":33111,"type":"SUBSTANTIAL MODIFICATION","status":"Authorised","ctNumber":"2022-503112-17-00","trialStatus":"Authorised","submissionDate":"2024-08-12","partI":{"assessmentOutcome":"acceptable","assessmentOutcomeDate":"2024-10-14"},"partIIInfo":[],"decisionDate":"2024-10-14","ctMSCsByApplication":[{"id":21030,"mscName":"Belgium","reportingStatusCode":"Authorised"},{"id":21031,"mscName":"Italy","reportingStatusCode":"Authorised"},{"id":20985,"mscName":"Spain","reportingStatusCode":"Ended"},{"id":20990,"mscName":"Germany","reportingStatusCode":"Ended"}],"businessKey":"SM-1","modScope":"PART_I","allPartTwosOutOfScope":false,"applicationTrialDecisionByMsc":{},"decisions":[{"id":41870,"applicationId":33111,"mscId":21030,"mscName":"Belgium","decisionDate":"2024-10-14T16:11:54.079","decision":"authorized","eventType":"decision","part1Id":50437,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":true},{"id":42270,"applicationId":33111,"mscId":21031,"mscName":"Italy","decisionDate":"2024-10-16T17:29:16.861","decision":"authorized","eventType":"decision","part1Id":50437,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":false},{"id":42715,"applicationId":33111,"mscId":20985,"mscName":"Spain","decisionDate":"2024-10-21T10:33:26.954","decision":"authorized","eventType":"decision","part1Id":50437,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":false},{"id":42476,"applicationId":33111,"mscId":20990,"mscName":"Germany","decisionDate":"2024-10-18T06:55:41.563","decision":"authorized","eventType":"decision","part1Id":50437,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":false}]},{"id":44831,"type":"SUBSTANTIAL MODIFICATION","status":"Authorised","ctNumber":"2022-503112-17-00","trialStatus":"Authorised","submissionDate":"2025-02-03","partI":{"assessmentOutcome":"acceptable","assessmentOutcomeDate":"2025-04-22"},"partIIInfo":[{"id":196574,"mscId":21030,"mscInfo":{"id":21030,"mscName":"Belgium","countryOrganisationId":2002,"assessmentOutcome":"acceptable","assessmentOutcomeDate":"2025-04-18","decision":"authorized_conditions","decisionDate":"2024-06-03","reportingStatusCode":"Authorised","countryName":"Belgium","trialStatus":"Authorised","firstDecisionDate":"2024-06-03"},"applicationStatusCode":"Authorised"},{"id":181175,"mscId":21031,"mscInfo":{"id":21031,"mscName":"Italy","countryOrganisationId":2018,"assessmentOutcome":"no_conclusion","assessmentOutcomeDate":"2025-03-24","decision":"authorized_conditions","decisionDate":"2024-06-07","reportingStatusCode":"Authorised","countryName":"Italy","trialStatus":"Authorised","firstDecisionDate":"2024-06-07"},"applicationStatusCode":"Authorised"}],"decisionDate":"2025-04-23","ctMSCsByApplication":[{"id":21030,"mscName":"Belgium","reportingStatusCode":"Authorised"},{"id":21031,"mscName":"Italy","reportingStatusCode":"Authorised"}],"businessKey":"SM-2","modScope":"PART_I_AND_PART_II","allPartTwosOutOfScope":false,"applicationTrialDecisionByMsc":{},"decisions":[{"id":69194,"applicationId":44831,"mscId":20990,"mscName":"Germany","decisionDate":"2025-04-29T00:00:00","decision":"authorized","eventType":"decision","part1Id":81706,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":false},{"id":68160,"applicationId":44831,"mscId":20985,"mscName":"Spain","decisionDate":"2025-04-23T12:19:54.842","decision":"authorized","eventType":"decision","part1Id":81706,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":false},{"id":68370,"applicationId":44831,"mscId":21031,"mscName":"Italy","decisionDate":"2025-04-24T12:48:59.094","decision":"authorized","assessmentOutcome":"no_conclusion","eventType":"decision","part2Id":181175,"part1Id":81706,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":false},{"id":68456,"applicationId":44831,"mscId":21030,"mscName":"Belgium","decisionDate":"2025-04-24T15:32:44.719","decision":"authorized","assessmentOutcome":"acceptable","eventType":"decision","part2Id":196574,"part1Id":81706,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":true}]},{"id":59978,"type":"SUBSTANTIAL MODIFICATION","status":"Authorised","ctNumber":"2022-503112-17-00","trialStatus":"Authorised","submissionDate":"2025-07-14","partI":{"assessmentOutcome":"acceptable","assessmentOutcomeDate":"2025-10-16"},"partIIInfo":[{"id":229060,"mscId":21030,"mscInfo":{"id":21030,"mscName":"Belgium","countryOrganisationId":2002,"assessmentOutcome":"acceptable","assessmentOutcomeDate":"2025-09-22","decision":"authorized_conditions","decisionDate":"2024-06-03","reportingStatusCode":"Authorised","countryName":"Belgium","trialStatus":"Authorised","firstDecisionDate":"2024-06-03"},"applicationStatusCode":"Authorised"},{"id":242804,"mscId":21031,"mscInfo":{"id":21031,"mscName":"Italy","countryOrganisationId":2018,"assessmentOutcome":"no_conclusion","assessmentOutcomeDate":"2025-10-13","decision":"authorized_conditions","decisionDate":"2024-06-07","reportingStatusCode":"Authorised","countryName":"Italy","trialStatus":"Authorised","firstDecisionDate":"2024-06-07"},"applicationStatusCode":"Authorised"}],"decisionDate":"2025-10-16","ctMSCsByApplication":[{"id":21030,"mscName":"Belgium","reportingStatusCode":"Authorised"},{"id":21031,"mscName":"Italy","reportingStatusCode":"Authorised"}],"businessKey":"SM-3","modScope":"PART_I_AND_PART_II","allPartTwosOutOfScope":false,"applicationTrialDecisionByMsc":{},"decisions":[{"id":94706,"applicationId":59978,"mscId":21031,"mscName":"Italy","decisionDate":"2025-10-21T19:50:56.009","decision":"authorized","assessmentOutcome":"no_conclusion","eventType":"decision","part2Id":242804,"part1Id":94875,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":false},{"id":93981,"applicationId":59978,"mscId":21030,"mscName":"Belgium","decisionDate":"2025-10-16T14:48:33.24","decision":"authorized","assessmentOutcome":"acceptable","eventType":"decision","part2Id":229060,"part1Id":94875,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":true}]},{"id":78281,"type":"SUBSTANTIAL MODIFICATION","status":"Authorised","ctNumber":"2022-503112-17-00","trialStatus":"Authorised","submissionDate":"2026-03-06","partI":{"assessmentOutcome":"acceptable_conditions","assessmentOutcomeDate":"2026-06-05"},"partIIInfo":[{"id":306328,"mscId":21030,"mscInfo":{"id":21030,"mscName":"Belgium","countryOrganisationId":2002,"assessmentOutcome":"acceptable","assessmentOutcomeDate":"2026-06-03","decision":"authorized_conditions","decisionDate":"2024-06-03","reportingStatusCode":"Authorised","countryName":"Belgium","trialStatus":"Authorised","firstDecisionDate":"2024-06-03"},"applicationStatusCode":"Authorised"},{"id":304271,"mscId":21031,"mscInfo":{"id":21031,"mscName":"Italy","countryOrganisationId":2018,"assessmentOutcome":"acceptable","assessmentOutcomeDate":"2026-06-04","decision":"authorized_conditions","decisionDate":"2024-06-07","reportingStatusCode":"Authorised","countryName":"Italy","trialStatus":"Authorised","firstDecisionDate":"2024-06-07"},"applicationStatusCode":"Authorised"}],"decisionDate":"2026-06-05","ctMSCsByApplication":[{"id":21030,"mscName":"Belgium","reportingStatusCode":"Authorised"},{"id":21031,"mscName":"Italy","reportingStatusCode":"Authorised"}],"businessKey":"SM-4","modScope":"PART_I_AND_PART_II","allPartTwosOutOfScope":false,"applicationTrialDecisionByMsc":{},"decisions":[{"id":127230,"applicationId":78281,"mscId":21030,"mscName":"Belgium","decisionDate":"2026-06-05T15:45:23.55","decision":"authorized_conditions","assessmentOutcome":"acceptable","eventType":"decision","part2Id":306328,"part1Id":122994,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":true},{"id":127956,"applicationId":78281,"mscId":21031,"mscName":"Italy","decisionDate":"2026-06-10T12:58:30.477","decision":"authorized_conditions","assessmentOutcome":"acceptable","eventType":"decision","part2Id":304271,"part1Id":122994,"applicationType":"SUBSTANTIAL MODIFICATION","isRMS":false}]},{"id":89893,"type":"NON SUBSTANTIAL MODIFICATION","status":"Authorised","ctNumber":"2022-503112-17-00","trialStatus":"Authorised","submissionDate":"2026-07-17","partI":{"assessmentOutcome":"acceptable_conditions","assessmentOutcomeDate":"2026-06-05"},"partIIInfo":[],"decisionDate":"2026-07-17","ctMSCsByApplication":[{"id":20985,"mscName":"Spain","reportingStatusCode":"Ended"},{"id":20990,"mscName":"Germany","reportingStatusCode":"Ended"},{"id":21030,"mscName":"Belgium","reportingStatusCode":"Authorised"},{"id":21031,"mscName":"Italy","reportingStatusCode":"Authorised"}],"businessKey":"NSM-2","modScope":"PART_I","allPartTwosOutOfScope":false,"applicationTrialDecisionByMsc":{},"decisions":[{"id":133453,"applicationId":89893,"mscId":20985,"mscName":"Spain","decisionDate":"2026-07-17T16:12:07.644","decision":"authorized","eventType":"decision","part1Id":137148,"applicationType":"NON SUBSTANTIAL MODIFICATION","isRMS":false},{"id":133453,"applicationId":89893,"mscId":20990,"mscName":"Germany","decisionDate":"2026-07-17T16:12:07.644","decision":"authorized","eventType":"decision","part1Id":137148,"applicationType":"NON SUBSTANTIAL MODIFICATION","isRMS":false},{"id":133453,"applicationId":89893,"mscId":21030,"mscName":"Belgium","decisionDate":"2026-07-17T16:12:07.644","decision":"authorized","eventType":"decision","part1Id":137148,"applicationType":"NON SUBSTANTIAL MODIFICATION","isRMS":true},{"id":133453,"applicationId":89893,"mscId":21031,"mscName":"Italy","decisionDate":"2026-07-17T16:12:07.644","decision":"authorized","eventType":"decision","part1Id":137148,"applicationType":"NON SUBSTANTIAL MODIFICATION","isRMS":false}]}],"trialGlobalEnd":[],"memberStatesConcerned":[{"mscName":"Spain","mscId":20985,"firstDecisionDate":"2024-06-10T09:34:12.202","lastDecisionDate":"2025-04-23T12:19:54.842","mscPublicStatusCode":8},{"mscName":"Germany","mscId":20990,"firstDecisionDate":"2024-06-06T13:32:25.682","lastDecisionDate":"2025-04-29T00:00:00","mscPublicStatusCode":8},{"mscName":"Belgium","mscId":21030,"firstDecisionDate":"2024-06-03T15:51:34.327","lastDecisionDate":"2026-06-05T15:45:23.55","mscPublicStatusCode":5},{"mscName":"Italy","mscId":21031,"firstDecisionDate":"2024-06-07T11:31:04.982","lastDecisionDate":"2026-06-10T12:58:30.477","mscPublicStatusCode":5}],"eudraCt":{"isTransitioned":false}},"events":{"temporaryHaltList":[],"trialEvents":[{"mscId":20985,"mscName":"Spain","events":[{"notificationType":"START_OF_TRIAL","date":"2024-10-23"},{"notificationType":"END_OF_TRIAL","date":"2024-12-16"}]},{"mscId":20990,"mscName":"Germany","events":[{"notificationType":"START_OF_TRIAL","date":"2024-10-21"},{"notificationType":"END_OF_TRIAL","date":"2024-12-16"}]},{"mscId":21030,"mscName":"Belgium","events":[{"notificationType":"START_OF_TRIAL","date":"2024-10-16"},{"notificationType":"START_OF_RECRUITMENT","date":"2024-10-17"},{"notificationType":"END_OF_RECRUITMENT","date":"2024-12-16"}]},{"mscId":21031,"mscName":"Italy","events":[{"notificationType":"START_OF_TRIAL","date":"2024-11-19"},{"notificationType":"START_OF_RECRUITMENT","date":"2025-05-14"},{"notificationType":"END_OF_RECRUITMENT","date":"2025-05-14"}]}],"unexpectedEvents":[],"seriousBreaches":[],"urgentSafetyMeasures":[]},"results":{},"documents":[{"title":"K1_SRP-9003-301_Recruitment-Arrangement_DE_Public","uuid":"c98533b2-c44b-4266-b754-62909368bca1","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Biopsy-Sheet_DE-German_Public","uuid":"44091002-2db5-481e-994a-be3ae55646a4","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1-0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Brochure_DE-German_Public","uuid":"05a00fcd-e236-4da7-9712-7ba8d460b1f0","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Flyer_DE-German_Public","uuid":"6f36cc6c-472a-4edd-a272-a32724d4267f","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Gene-Therapy-Sheet_DE-German_Public","uuid":"4ef464ad-c830-4cf0-aac1-5fb0a60600ed","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Informed-Consent-Flowchart_DE-German_Public","uuid":"1d54d60f-4e36-4e49-9edd-d8f4835b82e3","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Rollover-Letter_DE-German_Public","uuid":"d99d28d5-2c1c-47f0-acf6-181c451eb580","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_Assent-Form_7-12y_DE-German_Public","uuid":"6e134d06-4a20-4b44-94bf-ceecb53ab409","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_Assent-Form_13-17y_DE-German_Public","uuid":"f6091dcf-74ea-47aa-a653-ad02f0313a62","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"2"},{"title":"L1_SRP-9003-301_Greenphire-Consent_DE-German_Public","uuid":"3d34b436-ae64-4270-ad9c-1ea4f1511b09","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_Main-ICF_adult-parentguardian_DE-German_Public","uuid":"d046df90-f806-42ed-a392-57c3a9a14bb4","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"2.01"},{"title":"L1_SRP-9003-301_Optional G-FR-ICF_DE-German_Public","uuid":"ca4b40ff-aa4a-4b8a-9971-69f03439d330","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_Pregnant-Participant-Assent_DE-German_Public","uuid":"2d48bfa3-53a1-4f0f-b297-c9cc636ed220","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_Pregnant-Participant-ICF_DE-German_Public","uuid":"e7b56722-2c7c-418d-b89f-aa03b8a7b9ac","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_Pregnant-Partner-Assent_DE-German_Public","uuid":"b8895090-159a-4ac0-abb4-97a95177ee64","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_Pregnant-Partner-ICF_DE-German_Public","uuid":"471eefb1-2167-4b60-9526-4320d1cc0141","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"L2_SRP-9003-301_Qualification-Consent-ECHO_DE-German_Public","uuid":"0c4d7fcb-cd07-42c8-88fb-57b531e9a35d","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"L2_SRP-9003-301_Qualification-Consent-M_DE-German_Public","uuid":"171be7db-e480-4d60-9c61-cb899fa07364","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"L2_SRP-9003-301_Qualification-Consent-P_DE-German_Public","uuid":"1a5cde3d-039e-45c9-9918-42e9cda98486","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":125946,"manualVersion":"1.0","systemVersion":"1"},{"title":"K1_SRP-9003-301_Recruitment-Informed-Consent-Procedure_BE_Public","uuid":"cebf900d-0144-463f-b5dc-5fb92530c78f","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"n/a","systemVersion":"1"},{"title":"K2_SRP-9003-301_Biopsy-Sheet_BE_Dutch_Public","uuid":"27bef4bd-fcb2-4d0b-9d29-629e8df69006","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Biopsy-Sheet_BE_French_Public","uuid":"fb0c26c8-6d3e-4a16-8a1a-eefacdee88ec","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Biopsy-Sheet_BE_German_Public","uuid":"132a4a54-6de1-43bf-8b17-5d078de69b7f","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Brochure_BE_Dutch_Public","uuid":"c0e0acd6-48d5-429a-afe7-a6f78defac22","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Brochure_BE_French_Public","uuid":"be60f77f-b215-47c8-ac05-0f2e3d749acf","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Brochure_BE_German_Public","uuid":"6e37bfa7-4e2d-49ab-9847-7f6219e511a3","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Flyer_BE_Dutch_Public","uuid":"014f7ec0-73d7-4630-8a90-9060c9a230e8","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Flyer_BE_French_Public","uuid":"04c85301-295c-4c7d-bef9-2d1144476ede","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Flyer_BE_German_Public","uuid":"68560e9f-7073-4b02-9974-7d8d65faf755","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Gene-Therapy-Sheet_BE_Dutch_Public","uuid":"ea8c4500-fbb2-4bac-a303-32750fa6e71b","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Gene-Therapy-Sheet_BE_French_Public","uuid":"f852bd78-7974-47cc-a094-07da6e38a57c","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Gene-Therapy-Sheet_BE_German_Public","uuid":"1e2ab1b4-c543-4082-a571-755741c51171","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Informed-Consent-Flowchart_BE_Dutch_Public","uuid":"e6e744ce-979e-4cc7-885d-62df6285ce5b","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Informed-Consent-Flowchart_BE_French_Public","uuid":"f773ca4d-dc78-4b22-9fa2-06e10dd65af9","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Informed-Consent-Flowchart_BE_German_Public","uuid":"700595b3-3b99-44bc-85cc-3af446665d92","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Rollover-Letter_BE_Dutch_Public","uuid":"e4fa7909-4824-400d-bb50-8f451f094ae1","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Rollover-Letter_BE_French_Public","uuid":"5397a344-7b8e-4db6-82a8-ac68ac2da276","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_Rollover-Letter_BE_German_Public","uuid":"4f10002e-7154-433f-aa5f-8f8c9f882445","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_Assent Form 7-11_BEL_nld_Public","uuid":"e1e23e07-ea25-48b6-98af-476c6bf0d3f8","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Assent Form 7-11_BEL_eng_Public","uuid":"e712da7c-c039-4236-8936-19f570ba1f70","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Assent Form 7-11_BEL_fra_Public","uuid":"03ea9ab0-62c4-40ea-837c-9aa0a858738c","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Assent Form 12-17_BEL_nld_Public","uuid":"e8659253-e730-4245-b3d4-2b6c2a951dd5","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"4"},{"title":"L1_SRP-9003-301_Assent Form 12-17_BEL_eng_Public","uuid":"63c487ff-809b-4abe-9bf4-f29f955cba0f","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"4"},{"title":"L1_SRP-9003-301_Assent Form 12-17_BEL_fra_Public","uuid":"d3d180cf-50ed-4583-96d2-d4cca207c6fa","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"4"},{"title":"L1_SRP-9003-301_Main-ICF_BEL_nld_Public","uuid":"22aca506-bb5c-40ac-b1e8-7e4b45bdc9ef","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"5.0","systemVersion":"7"},{"title":"L1_SRP-9003-301_Main-ICF_BEL_eng_Public","uuid":"dde7417f-7a67-4a28-a16c-33c14eb8ffe7","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"5.0","systemVersion":"7"},{"title":"L1_SRP-9003-301_Main-ICF_BEL_fra_Public","uuid":"004823e2-dfe5-4f5a-b024-b69d96ba1ef1","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"5.0","systemVersion":"7"},{"title":"L1_SRP-9003-301_Assent Pregnant Participant ICF_BEL_nld_Public","uuid":"ae2eec1d-fdd2-4f81-a6d2-4a1841ca1f24","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Assent Pregnant Participant ICF_BEL_eng_Public","uuid":"a7997535-7583-4e17-a8b3-953de900ebb6","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Assent Pregnant Participant ICF_BEL_fra_Public","uuid":"c1230bee-c135-4cb9-a30e-8577af4262ea","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Pregnant Participant ICF_BEL_nld_Public","uuid":"baa4a6c5-29b9-47e8-977c-51b738d957a7","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Pregnant Participant ICF_BEL_eng_Public","uuid":"61c23c2d-94ae-4dd4-8bd9-396062d2c0f3","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Pregnant Participant ICF_BEL_fra_Public","uuid":"6a90e302-be04-4548-a37d-ede336f78958","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Assent Pregnant Partner ICF_BEL_nld_Public","uuid":"6dbb9c79-96ba-4e1f-8f19-f510f47ae1d4","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Assent Pregnant Partner ICF_BEL_eng_Public","uuid":"65604392-7dc2-4cc1-a079-c6244a597aba","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Assent Pregnant Partner ICF_BEL_fra_Public","uuid":"79c2fa00-239c-4800-8c82-ab25676b344f","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Pregnant Partner ICF_BEL_nld_Public","uuid":"23a676a1-7c14-4ad0-8952-cb42561fa953","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Pregnant Partner ICF_BEL_eng_Public","uuid":"54ee0471-686d-4592-9ce1-a137ec31268e","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Pregnant Partner ICF_BEL_fra_Public","uuid":"069584a5-2d13-4301-ad8e-1ff73468ddaf","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Qualification ICF ECHO_BEL_nld_Public","uuid":"66230304-5b18-4cb9-adce-005b4cb38b59","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Qualification ICF ECHO_BEL_eng_Public","uuid":"c8bdec8e-db66-47e7-bdea-79ed107529c6","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Qualification ICF ECHO_BEL_fra_Public","uuid":"c5cc795f-00a0-41e1-a6a2-854622be6fee","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Qualification ICF MRI_BEL_nld_Public","uuid":"8ae4fda4-ddde-4723-9356-4930dd2001e6","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Qualification ICF MRI_BEL_eng_Public","uuid":"c5d2748a-d49c-4ede-86fb-77739778ee09","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Qualification ICF MRI_BEL_fra_Public","uuid":"04c7a6c9-76c8-4694-8c57-a78339f32fe9","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Qualification ICF PFT_BEL_nld_Public","uuid":"0c659de8-3ff0-4d02-8c79-a0ff6d211e17","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Qualification ICF PFT_BEL_eng_Public","uuid":"2fbd38b4-8164-4629-8b66-201b4f8f32fd","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Qualification ICF PFT_BEL_fra_Public","uuid":"0537a7ac-22b9-46f0-91f8-d3cf639b3582","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Note to File ICF_Versioning_BE_English","uuid":"69795cc8-a710-459a-8cdb-c2770f95289b","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":306328,"manualVersion":"n/a","systemVersion":"1"},{"title":"K1_SRP-9003-301_Recruitment-Arrangements_IT_Italian_Public","uuid":"8f88e58a-cd40-4201-b74b-e54832a4d18a","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"N/A","systemVersion":"1"},{"title":"K2_Sarepta_SRP-9003-301_Biopsy Sheet_IT_Italian_Public","uuid":"8693893f-e1ac-4fbb-bb83-4627cc8dc4e3","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_Sarepta_SRP-9003-301_Brochure_IT_Italian_Public","uuid":"45feab75-8f9a-49cf-8022-67b4e6444569","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_Sarepta_SRP-9003-301_Flyer_IT_Italian_Public","uuid":"2bfb1021-1844-4ca3-a6e5-546d2f80c69c","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_Sarepta_SRP-9003-301_Gene Therapy Sheet_IT_Italian_Public","uuid":"0bbe2317-f5bb-45f0-9300-80f8d798fa03","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"1"},{"title":"K2_SRP-9003-301_GP Letter_IT_Italian_Clean_Public","uuid":"0f5773a5-630e-4d81-b431-f0ae7bad160d","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"5.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Assent 7-12_IT_Italian_Public","uuid":"3f101e25-d6b3-44a9-b723-66b3eb190a8c","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_Assent 13-18_IT_Italian_Public","uuid":"42d74dc0-468a-472f-8c4e-a8352eb551e5","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_ECHO ICF_IT_Italian_Public","uuid":"a751e927-b38e-4767-b2ee-bcf12082b344","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_HHC_IT_Italian_Public","uuid":"152b1bfc-0fef-40bb-a7c1-d3b421a8fa5c","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_M_ICF_IT_Italian_Public","uuid":"63b4749e-24fc-4b0e-b87c-355fa2071659","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Main Adult ICF_IT_Italian_Public","uuid":"86d3ae38-2dfa-4367-917d-960029ecfd9b","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"5.0","systemVersion":"5"},{"title":"L1_SRP-9003-301_Opt_G_ICF_IT_Italian_Public","uuid":"e3954638-8bd6-4945-a7bb-b3aca52ab938","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"1"},{"title":"L1_SRP-9003-301_P_ICF_IT_Italian_Public","uuid":"fbb2d833-55f1-4529-a22c-a170c4c326c1","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"3"},{"title":"L1_SRP-9003-301_Parents ICF_IT_Italian_Public","uuid":"48ff2c86-e3d2-445b-a3cf-751494440d7f","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"5.0","systemVersion":"5"},{"title":"L1_SRP-9003-301_Pregnant Participant Assent_IT_Italian_Public","uuid":"d5ab16ed-2321-47fc-afe9-4b39947842eb","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"2"},{"title":"L1_SRP-9003-301_Pregnant Participant_IT_Italian_Public","uuid":"9672632d-2e31-439b-8fc9-3ea2dd0ba171","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"2"},{"title":"L1_SRP-9003-301_Pregnant Partner Assent_IT_Italian_Public","uuid":"6baba955-aec6-48aa-a322-0828c04f7dbd","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"2"},{"title":"L1_SRP-9003-301_Pregnant Partner_IT_Italian_Public","uuid":"a693aad8-8bb4-49cb-b46c-1808b23dfda4","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"1.0","systemVersion":"2"},{"title":"L1_SRP-9003-301_Privacy ICF_IT_Italian_Public","uuid":"98c82d39-c63a-4203-b7c5-b68d7c8d9199","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":304271,"manualVersion":"5.1","systemVersion":"4"},{"title":"D1_Sarepta_SRP-9003-301_Protocol_2022-503112-17-00_Public","uuid":"15c28836-3771-4e0d-bc69-ab01a18d95f3","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"4.0","systemVersion":"5"},{"title":"D4_Sarepta_SRP-9003-301_ EQ-5D-5L-Paper Self-Complete_ENG_Public","uuid":"50cbb50e-51a2-4b2d-aa07-09519dc395ff","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SPR_9003-301_PROMIS Parent Proxy Bank-Mobility_ESP_Public","uuid":"b3881294-8874-443b-bc4c-59c2616f36f7","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_ACTIVLIM_AU_DEU_Public","uuid":"9bcf07b9-7832-4e28-aad3-11f517626cbd","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_ACTIVLIM Instructions and Questionnaires_ENG_Public","uuid":"f7ec28dd-8e8f-4375-8bf3-dd52266a7164","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_ACTIVLIM_sheets_ESP_Public","uuid":"bcc9cbdb-f3cf-4770-8430-2ca8af92d8cf","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_ACTIVLIM_sheets_ITA_Public","uuid":"303895a4-8e2f-40e4-a75e-99a61720669a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_ACTIVLIM-sheets_BE_DEU_Public","uuid":"980b235d-df8f-4bbf-adea-2cc5e565aa98","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_ACTIVLIM-sheets_BE_DUT_Public","uuid":"d43f5eba-fb2e-49e9-add0-27f59275ea45","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_ACTIVLIM-sheets_BE_FRA_Public","uuid":"35abf5aa-d816-460e-b92e-1d53a247f0c0","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Ambulatory_BE_DEU_Public","uuid":"27d23d1a-e08a-4c71-9854-59fc354d043f","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Ambulatory_BE_FRA_Public","uuid":"a55751e7-4272-42f7-b7e1-2a9dde997da9","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Ambulatory_BE_DUT_Public","uuid":"4c62877c-25b5-48d5-b6d3-c25d4c313e11","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Ambulatory_ENG_Public","uuid":"976e3a1f-713b-4ff0-aa80-64fa4fbfaa50","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Ambulatory_DEU_Public","uuid":"62eb2653-3b62-4e60-a044-5d11e1408a75","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Ambulatory_ESP_Public","uuid":"61288723-c86b-4913-aca9-bd8c7cc88364","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Ambulatory_ITA_Public","uuid":"e4b73497-ae69-43fd-8fdb-a5960f9c377c","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Non-Ambulatory_BE_DUT_Public","uuid":"ddd03bfd-7886-4e88-b9f9-b8541e85ff59","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Non-Ambulatory_BE_DEU_Public","uuid":"7aaf3b9d-0b20-4d16-91e0-ba882e73e924","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Non-Ambulatory_BE_FRA_Public","uuid":"bc184080-8b39-4e68-8818-3f3a5273f8f1","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Non-Ambulatory_ENG_Public","uuid":"463b854a-889b-409b-a810-e57d87dec9b8","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Non-Ambulatory_DEU_Public","uuid":"5503d861-9c5b-45d4-ab22-2253d5958dfc","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Non-Ambulatory_ESP_Public","uuid":"6f0e1ad5-fe40-4233-b931-379c6605cd3d","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIC-LGMD-Non-Ambulatory_ITA_Public","uuid":"82451bc9-cf00-4c55-9d53-4bd7b00daa24","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Ambulatory_BE_DEU_Public","uuid":"3a2230a7-498a-4dee-9052-3c2d2e155420","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Ambulatory_BE_DUT_Public","uuid":"7e60982a-5e3e-4f40-a2b2-f0fc880fc68e","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Ambulatory_BE_FRA_Public","uuid":"490391e2-ec0b-4b5c-a9f8-9300b544fea5","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Ambulatory_DEU_Public","uuid":"77547746-ce53-41a4-b112-464540f1323a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Ambulatory_ENG_Public","uuid":"c5edbe53-e185-4ac4-8756-557a434f66ee","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Ambulatory_ESP_Public","uuid":"0a38efb3-0866-408c-8308-8e90b234258a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Ambulatory_ITA_Public","uuid":"948c1487-66a2-4dc7-94ea-ee8d19d18850","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Non-Ambulatory_BE_FRA_Public","uuid":"c1ce5392-e67c-4f68-a3f6-c66d55d188c3","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Non-Ambulatory_BE_DUT_Public","uuid":"35d8c580-d586-4676-b82c-b0bfeab0b4fa","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Non-Ambulatory_BE_DEU_Public","uuid":"3c209227-fa09-473e-bb89-36ececd88f94","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Non-Ambulatory_DEU_Public","uuid":"686fa2ed-30f8-4057-b338-19097862426c","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Non-Ambulatory_ENG_Public","uuid":"347867ab-94f8-4303-99b6-ef5d8b99c22a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Non-Ambulatory_ITA_Public","uuid":"73093f5e-89eb-4618-9324-098bee9b7bc7","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_CaGIS-LGMD-Non-Ambulatory_ESP_Public","uuid":"bc2faf0e-8347-46d0-a53c-6f4033136219","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-5L Paper Proxy1_ESP_Public","uuid":"0dad9f35-cd54-441a-9baf-a6a54622d14f","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-5L Paper Proxy1_ITA_Public","uuid":"22282d3f-c125-46c4-b295-7c0b7d7043e6","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.2","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-5L Paper Self-Complete_ESP_Public","uuid":"50ef7923-90c5-490a-9349-c853c2faf2b7","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-5L Paper Self-Complete_ITA_Public","uuid":"4c4918fd-cbf5-4efb-a096-841724b1d442","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-5L-Paper-Proxy_BE_DEU_Public","uuid":"4a22a066-e66a-4c00-99fb-11ea55c695bd","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.2","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-5L-Paper-Proxy_BE_DUT_Public","uuid":"f10c5715-8ddf-4ffb-9793-ef38c058d8b2","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-5L-Paper-Proxy_BE_FRA_Public","uuid":"1e6c06ec-cdb7-49a5-a434-8177ef44d9c8","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-5L-Paper-Self-Complete_BE_DEU_Public","uuid":"e4a793de-55df-46c4-a859-ea725a2eca33","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-5L-Paper-Self-Complete_BE_FRA_Public","uuid":"eb35fe45-3f4b-4929-8806-045e2d106575","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-5L-Paper-Self-Complete_BE_DUT_Public","uuid":"8cfa17ff-3fe1-4e4d-a37d-db4bd453218c","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-Y Paper Self-Complete_ESP_Public","uuid":"f880f188-a448-4fb3-bdd6-3466e48bd97b","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-Y Paper Self-Complete_ITA_Public","uuid":"db8b7961-07a0-4350-a4ae-d3cd83ca47e7","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-Y_Paper_Self-Complete_BE_DUT_Public","uuid":"d6c59a0f-b4bc-40f1-a161-fa46d9834beb","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-Y_Paper_Self-Complete_BE_FRA_Public","uuid":"3e869119-6315-4821-aea7-d0ef626d5bf0","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_Effective_EQ-5D-Y_Paper-Self-Complete_BE_DEU_Public","uuid":"48cb2bce-fb26-432c-ba4d-3a79328bad4f","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_EQ-5D-5L- Paper Proxy1_ENG_Public","uuid":"c39ca8f7-c5af-4c3a-b341-fc1de82dd2fb","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_EQ-5D -Y-Paper-Self-Complete_ENG_Public","uuid":"846f66dc-dbf0-43ea-a46c-0849a7b1b666","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_EQ-5D-5L_Digital_Proxy1_DEU_Public","uuid":"4e55fed5-2b60-4425-998e-7935639e3201","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_EQ-5D-5L_Digital_Self-Complete_DEU_Public","uuid":"7fe04bf8-affd-4f24-bf1e-8be4aac5fe06","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_EQ-5D-5L_Paper_Proxy1_DEU_Public","uuid":"5f16dc6e-2b91-448b-8cdd-8bc016922dd8","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_EQ-5D-5L_Paper_Self-Complete_DEU_Public","uuid":"97760e91-957c-4fbb-beb2-43c53820da3a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_EQ-5D-Y_Digital_Self-Complete_DEU_Public","uuid":"0c4419d6-0330-4aa3-a5e2-c426d15adc4e","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_EQ-5D-Y_Paper_Self-Complete_DEU_Public","uuid":"8a367573-bfe4-47a7-90c4-3fe1f70d84e1","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.2","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Ambulatory_BE_DEU_Public","uuid":"aa8177b3-1ee4-47ba-aa50-2b8f6299128e","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Ambulatory_BE_DUT_Public","uuid":"c04b8d13-0060-4c61-8297-bf99b7a6bfe8","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Ambulatory_BE_FRA_Public","uuid":"e1597f29-6fee-4188-b6c4-445ce02a6b9a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Ambulatory_DEU_Public","uuid":"41064a0e-aea9-4a21-bfa7-284f09ee5746","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Ambulatory_ESP_Public","uuid":"b865f2e6-0baf-4c0c-b1ff-96b0b97da7eb","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Ambulatory_ITA_Public","uuid":"0ee5c614-8be3-4788-b046-9f4982eeaab0","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Non-Ambulatory_BE_DEU_Public","uuid":"0c2c8fb2-feeb-4a88-99ad-aeb0341989c3","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Non-Ambulatory_BE_FRA_Public","uuid":"a95d36fd-120c-49d1-8383-f31130dbb58a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Non-Ambulatory_BE_DUT_Public","uuid":"132ae4e9-7422-484e-844f-9ba0f7841211","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Non-Ambulatory_DEU_Public","uuid":"ef32277c-4d07-4002-b0e7-24c9960c29fd","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Non-Ambulatory_ENG_Public","uuid":"c5f3ca16-ddd8-4605-bec0-d58ff8baac92","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Non-Ambulatory_ESP_Public","uuid":"d8d95b94-1cee-4338-9d66-6854ecaa1495","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Non-Ambulatory_ITA_Public","uuid":"4c3c49b5-655e-4056-87db-ffe67490602a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Ambulatory_BE_DEU_Public","uuid":"0fa174cf-e1c8-4bb9-b3dc-ea867376613b","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Ambulatory_BE_DUT_Public","uuid":"30602d3c-bdae-4d13-b105-743d70cfbe5f","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Ambulatory_BE_FRA_Public","uuid":"4feadb6c-1549-422f-ae80-a9cfc27c99aa","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Ambulatory_DEU_Public","uuid":"8f618e98-4f73-4b63-ac52-5c609d99dd0d","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Ambulatory_ENG_Public","uuid":"1f15f155-e643-49b5-8320-3250900b47bb","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Ambulatory_ESP_Public","uuid":"7610a059-a701-4d62-9404-ee866e24dd54","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Ambulatory_ITA_Public","uuid":"2c49df61-fc2b-4210-aa9d-66080fa125c9","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Non-Ambulatory_BE_FRA_Public","uuid":"a5329478-4c17-44b6-8790-9a4cfc7c87c5","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Non-Ambulatory_BE_DEU_Public","uuid":"052ac108-9692-4a15-9d71-a1d6d1da6a4b","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Non-Ambulatory_BE_DUT_Public","uuid":"759e7515-9065-41f7-a979-8a97c4fd6062","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Non-Ambulatory_ITA_Public","uuid":"541adfcc-92c3-493a-882a-f8b997d6f2e1","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Non-Ambulatory_ENG_Public","uuid":"e8b952c2-b9be-4d60-82fc-0c3675d70f6e","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Non-Ambulatory_DEU_Public","uuid":"240c9274-6ae2-425b-ac21-2ba5371b694d","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIS-LGMD-Non-Ambulatory_ESP_Public","uuid":"bc399fb9-dedc-42e4-b195-219b244b0577","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Adult Fatigue 7a-SF_ITA_Public","uuid":"0c06f039-6543-418a-a482-cc9fd95f6667","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Adult Mobility_ITA_Public","uuid":"414328ff-6e09-4e19-a3ce-b92264f228ca","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Adult Upper Extremity Bank_ITA_Public","uuid":"737df53d-488a-4451-ae4e-4860ca5ea1f2","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Adult Upper Extremity 7a-SF_ITA_Public","uuid":"4acd9157-1496-4a08-88ba-8a64acd009fb","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Bank-Mobility_ESP_Public","uuid":"a3c39fb2-1e55-4b9c-8aef-34fc43617a48","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Bank-Upper Extremity_ESP_Public","uuid":"c8631def-62d8-41ec-a4c5-d99a3709e88f","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Bank_Mobility_ENG_Public","uuid":"4a86a4fe-7028-469c-bd53-8b773036b946","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Bank-Upper Extremity_ENG_Public","uuid":"cb973360-8c19-4f61-9743-e982f25153ea","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Parent Fatigue 10a-SF_ITA_Public","uuid":"8678be7a-c5d0-4e44-bdc4-8e6567049a52","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Parent Proxy Bank_Upper Extremity_Eng_Public","uuid":"6c189570-bbec-4e89-9e91-bb7805c07211","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Parent Proxy Bank-Mobility_ITA_Public","uuid":"cb9f8cbb-dc99-4c63-94cb-e7f00bd332c3","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Parent Proxy Bank-Mobility_Eng_Public","uuid":"9ca17f3b-7e51-413c-a695-154c2f0b1a81","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Parent Proxy SF  Fatigue 10a_ESP_Public","uuid":"b82ebdbc-b131-4520-ad08-c9783275fbb6","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Parent Proxy Bank-Upper Extremity_ESP_Public","uuid":"18907f11-d406-4740-9b19-43b487fd9bb4","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Parent Proxy SF Fatigue 10a_ENG_Public","uuid":"2994f2ac-510c-46fd-a978-8156e504337b","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Parent Proxy SF-Upper Extremity 8a_ESP_Public","uuid":"e0ea3764-c80e-4869-8ff7-ade6143c0b36","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Parent Proxy Upper Extremity 8a-SF_ITA_Public","uuid":"ce2a514a-ffd9-45b7-8511-87fda47b8a2c","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Parent Proxy SF-Upper Extremity 8a_ENG_Public","uuid":"8fdf8cc0-6f30-4881-a431-56c4eddca2d5","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Pediatric Bank-Mobility_ITA_Public","uuid":"f587625c-3ba1-4cc5-b95a-5d11128bbee8","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Pediatric Fatigue 10a_ITA_Public","uuid":"512c8458-5b0e-4944-a1ea-f516080e38bb","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Pediatric Item Bank_Mobility_ENG_Public","uuid":"4bd30738-7a7f-485b-ba55-14eb0225ccea","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PGIC-LGMD-Ambulatory_ENG_Public","uuid":"6d7bf4c7-cdba-4e67-a695-9dfb228b6e13","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Pediatric Item Bank-Mobility_ESP_Public","uuid":"9494fc47-76f4-425a-aa98-3446ca116785","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Pediatric Item Bank-Upper Extremity_ESP_Public","uuid":"54def3ac-437a-4a9a-96fd-fb478995e678","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Pediatric Item Bank-Upper Extremity_ENG_Public","uuid":"024ee155-88b7-4d3c-b8d4-f3d4946041fe","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Pediatric SF-Fatigue 10a_ESP_Public","uuid":"acf5902a-0fa9-474c-bfab-14c0f9312abe","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Pediatric SF-Upper Extremity 8a_ENG_Public","uuid":"ff158959-9210-4f0c-8f49-b491bbc11c4a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Pediatric SF-Upper Extremity 8a_ESP_Public","uuid":"d8018451-1dad-44fe-9196-6e77a07dca14","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS Pediatric Upper Extremity 8a-SF_ITA_Public","uuid":"7d6bfc2d-95da-4711-8129-95a119927093","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS SF Fatigue 7a_ESP_Public","uuid":"41e049da-eb5f-4867-a7b1-8a03d5b11dc0","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS SF-Adult Fatigue-7a_ENG_Public","uuid":"cb1e5910-1d1c-4ae6-868a-fcfaeced0ba2","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS SF-Adult-Upper Extremity 7a_ENG_Public","uuid":"63b5ab0f-2fc2-4aa5-b0f7-402254e81f4d","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS SF-Upper Extremity 7a_ESP_Public","uuid":"b54a39af-4089-4ad9-b80d-5a9c3504b193","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Fatigue_SF-7a_BE_DEU_Public","uuid":"1331fa84-39f5-4513-9033-eb8646e4c03a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Fatigue_SF-7a_BE_DUT_Public","uuid":"ab1b0b6f-40dc-4c8e-bdeb-047018d967a2","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Fatigue_SF-7a_BE_FRA_Public","uuid":"9628c101-c078-42e8-bed6-9ff3e0392b71","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Mobility_BE_DEU_Public","uuid":"dcf1423d-b188-4084-8ce1-a244f53e250d","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Mobility_BE_DUT_Public","uuid":"7f8e91d6-5a0d-4842-88ce-b2ce227ae5b7","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Mobility_BE_FRA_Public","uuid":"50616d25-c23d-4686-b818-368e4974b99a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Upper-Extremity_BE_DEU_Public","uuid":"7a85df27-0fd0-41b3-a8c4-b1c629608ee6","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Upper-Extremity_BE_DUT_Public","uuid":"13d8cd77-716b-42bb-9d96-34bbca2d4a92","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Upper-Extremity_BE_FRA_Public","uuid":"bbdc01b2-4d5f-4ecb-9f7f-db251a5692ea","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Upper-Extremity-SF-7a_BE_DEU_Public","uuid":"788488c6-2059-4aa1-a540-cccd875070d0","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Upper-Extremity-SF-7a_BE_DUT_Public","uuid":"3c940cc9-f56e-4438-9fc2-eb9f62e29433","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Adult_Upper-Extremity-SF-7a_BE_FRA_Public","uuid":"aca7a94f-2427-4f7c-80c4-40bdca3e4d5b","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent_Fatigue_SF-10a_BE_DEU_Public","uuid":"5907dc75-14e6-4e00-838d-ed621aa9fc32","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent_Fatigue_SF-10a_BE_DUT_Public","uuid":"36657987-37ff-4e79-b2a6-d148cdae6f58","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent_Fatigue_SF-10a_BE_FRA_Public","uuid":"b5ac4e87-80c5-4a2d-83b5-490cff1eec5b","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent_Mobility_BE_DEU_Public","uuid":"332793bb-a525-4ea8-ab89-e372e38313b1","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent_Mobility_BE_DUT_Public","uuid":"72f5e4a4-55c0-40a0-959c-fb440df407bf","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent_Mobility_BE_FRA_Public","uuid":"35e2cbdc-4687-4cf7-8a50-8b7c4ec15b8a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent_Upper-Extremity_BE_DEU_Public","uuid":"33857331-de94-4b2b-8727-135779a02d23","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent_Upper-Extremity_BE_DUT_Public","uuid":"b244c900-6714-4f85-aedb-d043ee12b7ac","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent_Upper-Extremity_SF-8a_BE_DEU_Public","uuid":"90a5fe17-0de8-457d-8639-0a6811812c0e","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent_Upper-Extremity_SF-8a_BE_DUT_Public","uuid":"2f089393-925c-4efa-97e1-2a41cbcc544d","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent_Upper-Extremity_SF-8a_BE_FRA_Public","uuid":"daa0dba9-0e40-4eae-a371-1b1dacf0bdd0","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Fatigue_SF-10a_BE_DEU_Public","uuid":"3082eb12-8ff0-4056-8c39-770389d47e81","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Fatigue_SF-10a_BE_DUT_Public","uuid":"39ab8ced-71ba-4e3e-860a-0958abae393c","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Fatigue_SF-10a_BE_FRA_Public","uuid":"b44553ba-b1d9-4640-a968-a0c06e8d5e48","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Fatigue_SF-10a_ENG_Public","uuid":"1b8edcb6-1d77-4be3-a9cd-f536258e9fe9","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Mobility_BE_DEU_Public","uuid":"1304de71-b520-4c1f-8830-47014445c363","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Mobility_BE_DUT_Public","uuid":"911a84eb-7602-4dd4-9a0d-4d32e5fb0cb8","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Mobility_BE_FRA_Public","uuid":"e41a04d4-9492-455c-9329-0440893f4cab","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Upper Extremity_BE_DEU_Public","uuid":"d6b4a479-50a2-4367-8600-4ac510a7361f","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Upper Extremity_BE_DUT_Public","uuid":"0f5098d2-4b25-4b54-aeaf-263fbd05b8bb","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Upper Extremity_SF-8a_BE_DEU_Public","uuid":"68ad4d15-3c9b-41b8-a4b8-d285ebe8b2b8","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Upper Extremity_SF-8a_BE_DUT_Public","uuid":"baf9b35f-22aa-4f19-b42f-4a0eda2d2d9f","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric_Upper Extremity_SF-8a_BE_FRA_Public","uuid":"af1d9174-b73c-42f6-9142-db07ce85b4ff","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric-Item-Bank-Mobility_DEU_Public","uuid":"de961feb-89c9-4855-bcca-f9a92d4bb319","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS-Bank-Upper-Extremity_DEU_Public","uuid":"1a9956a6-fc27-4c1e-841b-130349a1ae6c","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS-Mobility_DEU_Public","uuid":"430cb705-a898-4958-9230-5358f3260b6c","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS-Parent-Proxy-Bank-Mobility_DEU_Public","uuid":"05dc147c-91b8-441b-bd65-98c818099c9b","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS-Parent-Proxy-Bank-Upper-Extremity_DEU_Public","uuid":"384e2ac2-ec9b-43b0-baac-35addcd70cc3","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS-Parent-Proxy-SF-Fatigue-10a_DEU_Public","uuid":"0c651d91-d4cf-4867-9c14-673633ccbd76","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS-Parent-Proxy-SF-Upper-Extremity-8a_DEU_Public","uuid":"68d351c7-84f5-420c-b268-2ccc4e20cbd2","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS-Pediatric-Item-Bank-Upper-Extremity_DEU_Public","uuid":"75f71004-778f-41a5-af97-394750a08277","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS-Pediatric-SF-Fatigue-10a_DEU_Public","uuid":"61ca22b0-30b7-489d-983d-11dda4f508f2","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS-Pediatric-SF-Upper-Extremity-8a_DEU_Public","uuid":"4ed3eeb7-61a9-400d-b836-79d5e79803cd","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS-SF_Upper-Extremity-7a_DEU_Public","uuid":"59568c9e-b12e-4dd3-9c79-c7a87687ddb0","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS-SF-Fatigue_7a_DEU_Public","uuid":"1d365d9a-0a54-40ee-8a83-9103867a505e","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":4,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D1_Sarepta_SRP-9003-301_DoseAdministrationManual_2022-503112-17-00_Public","uuid":"8f748bde-d67a-4654-b4d5-77fef2caddbf","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D1_Sarepta_SRP-9003-301_GeneTherapyBiopsyLabManual_2022-503112-17-00_Public","uuid":"6aa9696f-5b31-47d6-a4cb-e1cccc7660ec","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"5.0","systemVersion":"1"},{"title":"D1_Sarepta_SRP-9003-301_PharmacyManual_2022-503112-17-00_Public","uuid":"2572ca9f-4b34-4882-ba74-0789cdfd25b9","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D1_Sarepta_SRP-9003-301_VectorShedding-PKManual_2022-503112-17-00_Public","uuid":"b39eff7e-2e42-4551-8c29-da1a9fa94d86","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.0","systemVersion":"1"},{"title":"D1_Sarepta_SRP-9003-301_Syde Clinician Manual_2022-503112-17-00_Public","uuid":"66468980-df33-4d13-a603-0e4c6bb9a04e","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent Proxy Bank-Upper Extremity_ITA_Public","uuid":"1f4e34d8-5228-44f4-8d03-5b564833f1c3","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Parent-Upper Extremity_BEL_FRA_Public","uuid":"e94ce4db-c2bb-415a-8781-d05caa2230c0","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric Item Bank-Upper Extremity_ITA_Public","uuid":"90ce8164-2bcb-47a4-b3f1-1ca41f5a3bde","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D4_Sarepta_SRP-9003-301_PROMIS_Pediatric Item Bank-Upper Extremity_BEL_FRA_Public","uuid":"78c9efda-d602-45d0-bbc4-4bf501dd8b9a","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"2.0","systemVersion":"1"},{"title":"D1_Sarepta_SRP-9003-301_Protocol Clarification Letter_2022-503112-17-00_Public","uuid":"0597d34d-4cf1-4d1e-b773-f62fc89e97ca","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"N/A","systemVersion":"1"},{"title":"D1_Sarepta_SRP-9003-301_Protocol Synopsis_2022-503112-17-00_BE_DEU_Public","uuid":"aeb9cb78-cb78-481e-b7dd-6bbf1eba9c6e","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"4.0","systemVersion":"5"},{"title":"D1_Sarepta_SRP-9003-301_Protocol Synopsis_2022-503112-17-00_BE_DUT_Public","uuid":"4db4d325-086d-4ccb-9c9b-ed24916c97ea","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"4.0","systemVersion":"5"},{"title":"D1_Sarepta_SRP-9003-301_Protocol Synopsis_2022-503112-17-00_BE_FRA_Public","uuid":"6321b10f-803a-4f5c-b0b1-328d5fdda08b","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"4.0","systemVersion":"5"},{"title":"D1_Sarepta_SRP-9003-301_Lay Protocol Synopsis_2022-503112-17-00_BE_DUT_Public","uuid":"d13d59b0-3494-4033-a676-486a1d100128","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":36,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"3.0","systemVersion":"4"},{"title":"D1_Sarepta_SRP-9003-301_Protocol Synopsis_2022-503112-17-00_ESP_Public","uuid":"6413837d-4064-42d5-8223-2eb9c3316117","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.2","systemVersion":"3"},{"title":"D1_Sarepta_SRP-9003-301_Lay Protocol Synopsis_2022-503112-17-00_BE_DEU_Public","uuid":"db77b78f-03dd-44e7-9ac1-9515f5ab4838","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":28,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"3.0","systemVersion":"4"},{"title":"D1_Sarepta_SRP-9003-301_Lay Protocol Synopsis_2022-503112-17-00_BE_FRA_Public","uuid":"ed456bac-a557-4244-8c8c-e8d39a9e35db","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":33,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"3.0","systemVersion":"4"},{"title":"D1_Sarepta_SRP-9003-301_Lay Protocol Synopsis_2022-503112-17-00_ESP_Public","uuid":"15e915b7-d397-43e6-95db-464565b5f76b","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":7,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"2"},{"title":"D1_Sarepta_SRP-9003-301_Lay Protocol Synopsis_2022-503112-17-00_ITA_Public","uuid":"52b574b6-8868-4c2d-8f8e-2ca0e6f991f7","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"3.0","systemVersion":"4"},{"title":"D1_Sarepta_SRP-9003-301_Lay Protocol Synopsis_2022-503112-17-00_DEU_Public","uuid":"22d42b32-52e6-44e6-83db-dd709c00cacb","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":29,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"1.1","systemVersion":"2"},{"title":"D1_Sarepta_SRP-9003-301_Lay Protocol Synopsis_2022-503112-17-00_ENG_Public","uuid":"53642cdc-4783-404c-83e4-d195c529c0b4","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"3.0","systemVersion":"4"},{"title":"D1_Sarepta_SRP-9003-301_Protocol synopsis_2022-503112-17-00_ITA_Public","uuid":"b243ef2a-77b4-461e-9a89-56d8b534ef82","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":14,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"4.0","systemVersion":"5"},{"title":"D1_Sarepta_SRP-9003-301_Protocol Synopsis_2022-503112-17-00_ENG_Public","uuid":"723e87e1-c5b6-4cda-9ee0-3ba5a240a7ac","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137148,"manualVersion":"4.0","systemVersion":"5"}],"trialRegion":"Both","trialRegionCode":3,"correctiveMeasures":[]}